Give us a Call
+1 (915) 412-6680
Send us a Message
[email protected]
Opening Hours
Mon-Thu: 7 AM - 7 PM
Fri - Sun: Closed

The Gut-Immune System and Hormones Role in Overall Wellness

Dive into the world of the gut-immune system and hormones and their crucial role in supporting immune health and overall wellness.

Abstract

I wrote this educational post to share how I moved from medication stacks to a systems-biology model that begins in the gut and extends through the immune, endocrine, and nervous systems. Drawing on modern methods such as metagenomic sequencing, metabolomics, intestinal permeability assays, and autonomic measures (e.g., HRV), I explain how dysbiosis, leaky gut, and LPS-driven inflammation disrupt estrogen metabolism, thyroid hormone conversion, insulin sensitivity, and mood. You will learn why supporting the estrobolome, optimizing vitamin D3–K2–A cofactors, and balancing iodine–selenium for thyroid are pivotal. I discuss practical protocols using diet, prebiotics, probiotics, butyrate support, DIM/I3C, calcium D-glucarate, glutamine, methylation cofactors, and, when appropriate, shilajit to sustain free testosterone. I also show where integrative chiropractic care fits: improving vagal tone, diaphragmatic mechanics, and autonomic balance to normalize motility, lower inflammation, and help good plans work. Throughout, I reference my clinical observations from ChiroMed and the latest findings from leading researchers, so you can see the rationale behind each step and apply this roadmap safely and effectively.

Why I Now Start With The Gut, Then Layer Hormones, Thyroid, And Structure

I trained in conventional models and spent years optimizing hormones and metabolism. I prescribed intensively, studied incretins and GLP-1, and did everything I could to improve diabetes and endocrine care. Many patients improved—but too many plateaued. The turning point came when I consistently addressed gut integrity and the neuroimmune axis first: patients’ medication burdens decreased, weight and energy normalized, and mood and cycles stabilized. When I dug deeper into the 25–30% who still struggled, I found a common thread: dysbiosis, intestinal permeability, and autonomic dysregulation blocked progress.
My clinical lesson: persistent symptoms usually reflect a convergence of microbiome imbalance, barrier dysfunction, immune activation, autonomic imbalance, and environmental mismatch. These systems converge in the gut. That’s why my care integrates functional nutrition, targeted supplementation, hormone and thyroid optimization, and integrative chiropractic to restore nervous system balance and biomechanics. Across my clinical work at ChiroMed and case reflections I share on LinkedIn, a gut-first framework reliably transforms outcomes (Jimenez, n.d.-a; Jimenez, n.d.-b).

The Gut Microbiome As A Neuroendocrine And Immune Control Center

The microbiome is a living organ system. In a healthy state, it:

  • Produces short-chain fatty acids (SCFAs)—especially butyrate, propionate, and acetate—that fuel colonocytes, tighten epithelial tight junctions, and tame inflammation (Canfora et al., 2019).
  • Trains GALT and regulatory T cells (Tregs), fostering immune tolerance (Turnbaugh & Gordon, 2019).
  • Maintains barrier integrity, preventing lipopolysaccharide (LPS) translocation and downstream TLR4–NF-κB signaling (Camilleri, 2019).
  • Modulates neurotransmitters and the HPA axis, influencing serotonin via enterochromaffin cells and stress resilience (Cryan & Dinan, 2015).
  • Shapes hormone metabolism, including the estrobolome, insulin sensitivity, and thyroid conversion.

When dysbiosis develops, we see reduced butyrate-producing bacteria, an excess of pathobionts, and elevated beta-glucuronidase—an enzyme that can deconjugate estrogens and promote estrogen recirculation. Clinically, this presents as bloating, irregular stools, acne, brain fog, fatigue, weight plateaus, and hormone therapy that “doesn’t stick.” Mechanistically, increased LPS fuels systemic inflammation and insulin resistance; reduced SCFAs loosen junctions and weaken mucosal defense; and neuroendocrine signaling drifts toward anxiety, low mood, and poor sleep.

Intestinal Permeability, Zonulin, and the Inflammation–Endocrine Loop

“Leaky gut” is a measurable phenomenon. Tight junctions—regulated by proteins like claudin, occludin, and zonulin—hold epithelial cells together. When zonulin rises in response to gluten, infections, dysbiosis, or stress, the junctions loosen, allowing dietary antigens and microbial fragments to enter the circulation (Fasano, 2012). The consequences:

  • Immune activation: Elevated TNF-α and IL-6 amplify systemic inflammation.
  • Endocrine disruption: Cytokines increase cortisol and insulin, blunt T4→T3 conversion, and alter sex hormone balance.
  • Metabolic effects: Raised insulin and cortisol promote fat storage and alter appetite circuits.

Repeated postprandial endotoxemia (LPS spikes after meals) is well documented with high-fat, ultra-processed diets, fueling insulin resistance and barrier erosion (Cani et al., 2007). In my practice, I routinely see elevated zonulin, LPS-binding protein, low SCFAs, and high beta-glucuronidase in stressed, symptomatic patients. When we seal the barrier and calm LPS, endocrine therapies begin to work the way we expect.

The Estrobolome, Beta-Glucuronidase, And Estrogen Recirculation

The estrobolome—the gut microbial genes that metabolize estrogens—determines whether estrogens are excreted or recirculated. In the liver, estrogens are conjugated (often glucuronidated) and excreted via bile. If the microbiome produces excess beta-glucuronidase, it deconjugates estrogens in the intestine, thereby enabling reabsorption through the intestinal wall (Plottel & Blaser, 2011; Flores et al., 2012). Add constipation, and you compound recirculation. Clinically, I see:

  • Worsened PMS, mastalgia, fibrocystic changes, and heavier cycles.
  • Frustration with hormone therapy due to increased metabolites returning to circulation.
  • Mood variability and breast density changes when the 2-OH:16-OH balance is unfavorable.

Supporting fiber, calcium D-glucarate, DIM/I3C, methylation cofactors, bile flow, and daily bowel movements can reverse this loop.

PCOS, Endometriosis, And The Gut–Hormone Axis

  • PCOS: Dysbiosis raises LPS and zonulin, driving inflammation and insulin resistance, which increases ovarian theca cell androgen production. Result: hyperandrogenism, anovulation, acne, and metabolic risk (Qi et al., 2022). When I rebuild the barrier, raise SCFAs, and add resistance training with targeted nutrition, fasting insulin drops, cycles stabilize, and skin clears.
  • Endometriosis: Elevated beta-glucuronidase and permeability raise circulating estrogen and pelvic inflammation. Estrogen metabolism favors 2-hydroxylation over proliferative or genotoxic pathways when supported with DIM, I3C, methylation, and glucuronidation aids (Yager & Davidson, 2006; Taylor et al., 2020). My patients often report lighter cycles and reduced pain when transit improves, and recirculation decreases.

Thyroid Conversion, Iodine–Selenium Synergy, and Hashimoto’s

Thyroid function hinges on substrate availability and redox safety:

  • Iodine is essential for T4/T3 synthesis, but it must be managed carefully—especially in autoimmune thyroiditis.
  • Selenium-dependent enzymes (glutathione peroxidases, deiodinases) detoxify H2O2 used by TPO and convert T4 to T3. Low selenium levels increase oxidative stress and can heighten antibody activity; supplementation can lower TPO antibody levels in some patients (Gärtner et al., 2002).

In Hashimoto’s, dysbiosis and intestinal permeability elevate cytokine levels, impairing T4→T3 conversion and nutrient absorption (Caturegli et al., 2014). Correcting the microbiome, supporting the barrier, and using vitamin D3–K2–A with magnesium (for vitamin D metabolism) improves immune tolerance and thyroid status. In my clinic, combining selenium (100–200 mcg/day) with gut repair and stress modulation often stabilizes symptoms and antibody trends.

Vitamin D3, K2, Magnesium, And Vitamin A: Directing Calcium And Calming Immunity

Many patients take vitamin D3 without cofactors. For safety and efficacy:

  • Magnesium supports the enzymes that convert D into its active forms.
  • Vitamin K2 (MK-7) activates osteocalcin and matrix Gla protein (MGP), directing calcium to bones and away from arteries (Beulens et al., 2013).
  • Vitamin A (retinol) works synergistically with D and K to balance bone remodeling and epithelial integrity.

I generally target 25(OH)D at 50–70 ng/mL, titrating based on labs, with D3 taken with fat and magnesium, plus K2 (and judicious vitamin A when indicated) (Pilz et al., 2019; Mitchell et al., 2022). Clinically, this reduces musculoskeletal aches, improves mood and immune balance, and safeguards vascular health during endocrine optimization.

Akkermansia, SCFAs, And Metabolic Flexibility

I pay close attention to Akkermansia muciniphila, a mucin-degrading bacterium associated with stronger mucus layers and better metabolic profiles. Low levels of Akkermansia correlate with barrier fragility and weight-loss resistance (Everard & Cani, 2013). When I support mucosal nutrition (polyphenols from berries and pomegranates; prebiotic fibers; omega-3s), Akkermansia often rebounds. When combined with fiber-induced SCFAs, patients regain insulin sensitivity, see improved fasting glucose, and break stubborn weight plateaus.

Evidence-Based Tools That Inform Personalization

Modern research methods help move from guesswork to precision:

  • Metagenomics identifies microbial composition and functional genes (e.g., SCFA producers, Enterobacteriaceae) to target interventions (Turnbaugh & Gordon, 2019).
  • Metabolomics measures functional outputs—such as SCFAs, bile acids, and indoles—to gauge progress.
  • Permeability assays (e.g., serum zonulin, lactulose/mannitol) and markers like LPS-binding protein quantify barrier function (Camilleri, 2019).
  • Neurogastroenterology and HRV assessments tailor autonomic and motility interventions (Tracey, 2002).

This data-driven approach, combined with clinical observation, improves accuracy, safety, and recovery speed.

Integrative Chiropractic Care: Why Structure And Autonomics Matter

As a chiropractor and nurse practitioner, I witness how biomechanics and the autonomic nervous system shape gut and endocrine function:

  • Vagal tone: Gentle cervical work, rib mechanics, diaphragmatic release, and paced breathing increase parasympathetic output, improving gastric accommodation and GI motility, while reducing visceral hypersensitivity.
  • Spinal and pelvic mechanics: Thoracolumbar and sacral segments modulate sympathetic and parasympathetic outflow to the GI tract; restoring mobility reduces nociceptive drive and systemic cytokine levels.
  • Movement prescriptions: Rhythmic aerobic work and resistance training improve insulin sensitivity and myokine profiles, enhancing metabolic resilience.

In my practice, adding HRV-guided breathing, diaphragmatic training, and targeted adjustments accelerates gut recovery and stabilizes mood and sleep. Structural integration is not optional; it is central to steady autonomic balance and endocrine stability (Tracey, 2002; Cryan & Dinan, 2015; Jimenez, n.d.-a; Jimenez, n.d.-b).

DIM, I3C, And Safer Estrogen Metabolism

Diindolylmethane (DIM) and indole-3-carbinol (I3C) help steer estrogen toward the 2-hydroxy (2-OH) pathway, away from 4-OH quinone-prone and 16-OH proliferative metabolites. Mechanisms include modulation of CYP enzymes and support of COMT-mediated methylation (Bradlow, 2019; Kabat et al., 2006). In practice:

  • Women: DIM 100–150 mg/day, titrating up to 300 mg/day when PMS, mastalgia, or estrogen dominance persists.
  • Men: DIM 300 mg/day, up to 600 mg/day in select prostate risk scenarios while monitoring.

I pair DIM with methylated B vitamins and sulforaphane (Nrf2 activation) to ensure conjugation and detox pathways keep pace (Singh et al., 2011). Clinically, patients report improved breast density profiles and better tolerance to HRT when DIM is maintained.

Calcium D-Glucarate, Methylation, Bile Flow, And Daily Excretion

To reduce beta-glucuronidase reactivation and enterohepatic recirculation, I use:

  • Calcium D-glucarate to support glucuronidation.
  • Methylation support (methylfolate, methylcobalamin, B6/P5P, TMG) to detoxify catechol estrogens and maintain COMT function—especially when 4-OH is elevated.
  • Bile flow support with bitters (e.g., gentian, dandelion) and hydration to carry conjugated estrogens into the intestine.
  • Transit optimization with fiber and gentle movement. Constipation is a nonstarter—daily bowel movements are mandatory for estrogen safety.

This Phase I–II–III strategy ensures metabolites are formed safely (Phase I), conjugated (Phase II), and eliminated (Phase III).

Glutamine, Zinc Carnosine, And Mucosal Repair

When permeability is high or mucosal stress is severe, I deploy:

  • L-glutamine to fuel enterocytes and bolster tight junction protein expression.
  • Zinc carnosine to stabilize mucosal surfaces and reduce oxidative stress (Ueda et al., 2007).
  • Omega-3s and demulcents as needed.

Patients often experience reduced bloating, better stool quality, and calmer skin when mucosal repair is prioritized.

Shilajit And Free Testosterone: Sustaining Benefits Across Pellet Cycles

Late in testosterone pellet cycles, many patients report symptom drift despite acceptable total testosterone. The culprit is often a decline in free testosterone, the bioavailable fraction that drives receptor signaling. Purified shilajit has shown significant increases in both total and free testosterone (e.g., ~31% and ~51% respectively at 250 mg twice daily in a randomized, placebo-controlled trial), likely via fulvic acid–mediated mitochondrial and transport effects (Pandit et al., 2016). In my clinic:
Adding purified shilajit during the latter half of a pellet cycle stabilizes free testosterone without pushing total levels into side-effect territory.
Patients report steadier energy, drive, and recovery.
I integrate shilajit into a comprehensive HRT support stack (DIM, methylated B’s, sulforaphane, CoQ10) to support balanced metabolism and oxidative protection.
For women with PCOS or androgen sensitivity, I avoid raising androgens and instead emphasize estrogen detoxification and an insulin-sensitizing lifestyle.

Practical, Stepwise Clinical Plan

Here is how I typically structure care:

  • Phase 1: Calm the fire
    • Remove ultra-processed foods, dyes, and excess alcohol.
    • Establish hydration, protein adequacy, and high-fiber, polyphenol-rich meals.
    • Start multi-strain probiotics, prebiotics (inulin, FOS, GOS, resistant starch), and L-glutamine; add zinc carnosine if mucosal stress is evident.
    • Begin paced breathing (≈6 breaths/min), humming or gargling, and chiropractic sessions to downshift sympathetic tone.
    • Target sleep: a consistent schedule, a cool, dark room, and morning light.
  • Phase 2: Restore and rebalance
    • Add DIM/I3C based on symptoms or metabolite data; support methylation (methylfolate, B12, B6, TMG).
    • Introduce calcium D-glucarate for glucuronidation; enhance transit with diverse fibers.
    • Train with progressive resistance (3x/week) and zone 2 cardio (2x/week).
    • Ensure daily bowel movements and support bile flow with bitters.
  • Phase 3: Optimize and personalize
    • Reassess stool metrics (zonulin, SCFAs, beta-glucuronidase, Akkermansia) and hormone metabolites.
    • Correct nutrient deficits (vitamin D, magnesium, omega-3s, iron, zinc).
    • Support Akkermansia with polyphenols and mucin-feeding fibers; maintain D3–K2–A for calcium handling and immune balance.
    • For pellet-based HRT, consider shilajit to sustain free testosterone; for PCOS or estrogen dominance, lean on detox supports without increasing androgens.
    • Maintain integrative chiropractic care to reinforce autonomic balance and movement quality.

Modulating Women’s Hormones- Video

Clinical Observations From My Practice

From my work at ChiroMed and professional updates I share on LinkedIn:

  • Patients with “great labs” but persistent symptoms often harbor dysbiosis, increased permeability, or elevated beta-glucuronidase—addressing these unlocks progress (Jimenez, n.d.-a; Jimenez, n.d.-b).
  • Pairing resistance training with gut repair stabilizes cycles and insulin in PCOS; skin and mood follow.
  • Akkermansia repletion tracks with breaking weight-loss plateaus, even after GLP-1 use.
  • Integrative chiropractic care improves adherence and resilience—when pain and sleep improve, nutrition and movement protocols stick, accelerating gut and hormone balance.

Why These Techniques Work: Physiology-First Reasoning

  • Prebiotics and fiber → raise SCFAs, especially butyrate, tightening junctions and lowering inflammatory signaling (Canfora et al., 2019). This reduces LPS leakage and stabilizes endocrine pathways.
  • Synbiotics (probiotics + prebiotics) → re-seed commensals and feed them, improving stool form, immune markers, and motility in IBS and dysbiosis.
  • Glutamine and zinc carnosine → restore epithelial energy and mucosal structure, lowering antigen translocation (Ueda et al., 2007).
  • DIM/I3C → steer estrogen toward 2-OH and away from 4-OH/16-OH, lowering quinone burden and proliferative signaling (Bradlow, 2019; Kabat et al., 2006).
  • Methylation support → completes detox of catechol estrogens and protects DNA via COMT and related pathways.
  • Calcium D-glucarate → promotes glucuronidation and reduces beta-glucuronidase-driven recirculation.
  • D3–K2–A with magnesium → improves immune modulation and calcium trafficking, protecting bone and vasculature (Beulens et al., 2013; Pilz et al., 2019; Mitchell et al., 2022).
  • Iodine with selenium → restores thyroid hormone synthesis while protecting against H2O2-driven oxidative damage; supports deiodinases (Gärtner et al., 2002; Zimmermann, 2003).
  • Shilajit → raises free testosterone and supports mitochondrial function, smoothing symptom curves across pellet cycles (Pandit et al., 2016).
  • Chiropractic-informed autonomic care → increases vagal tone and reduces nociception, lowering cytokines and improving motility, digestion, and sleep (Tracey, 2002; Cryan & Dinan, 2015).

Putting It All Together: A Gut-First, Whole-Person Strategy

When we respect the body’s systems biology, we see why a gut-first strategy with autonomic balance makes hormones and thyroid therapies work predictably. By:

  • Sealing the barrier and raising SCFAs,
  • Lowering LPS and cytokines,
  • Steering estrogen metabolism toward safer pathways with DIM/I3C and ensuring excretion with calcium D-glucarate, fiber, and bile flow,
  • Optimizing vitamin D3–K2–A with magnesium and carefully integrating iodine–selenium for thyroid,
  • Supporting bioavailable androgens with shilajit when appropriate,
  • And integrating chiropractic care to normalize autonomic tone and movement.

We consistently move patients from symptom management to durable health. This approach is practical, measurable, and aligned with modern, evidence-based methods. In my experience, it is also the fastest, safest way to feel well and stay well.

References


SEO tags: gut health, dysbiosis, intestinal permeability, LPS, SCFAs, estrobolome, beta-glucuronidase, estrogen metabolism, DIM, I3C, calcium D-glucarate, vitamin D3, vitamin K2, vitamin A, iodine, selenium, Hashimoto’s, thyroid conversion, Akkermansia muciniphila, shilajit, free testosterone, HRT pellets, integrative chiropractic care, vagal tone, HRV, functional medicine, microbiome sequencing, metabolomics, NF-κB, TLR4, COMT, Nrf2

Hormone Optimization Techniques For Thyriod Health

Achieve optimal thyroid health through hormone optimization and support your body’s natural balance and energy.

Abstract

In this educational post, I will explore the nuanced and highly individualized world of hormone optimization, moving beyond rigid, population-based “normal” ranges to focus on patient-centered, evidence-based outcomes. We will delve into the physiological importance of key hormones like testosterone, thyroid hormones (T4 and T3), and progesterone, and discuss the complex considerations surrounding estrogen therapy, particularly for patients with a history of cancer. My goal is to illuminate the rationale behind a functional and integrative approach, emphasizing that true health is about how a patient feels and functions, supported by data, not just about achieving a specific number on a lab report. We will discuss why a low testosterone level, even if the patient feels “normal,” poses significant long-term health risks, including increased all-cause mortality, type 2 diabetes, and Alzheimer’s disease. Furthermore, I’ll explain how integrative chiropractic care, by addressing the body’s structural and neurological integrity, provides a foundational pillar of support for these hormonal therapies, enhancing overall physiological function and patient well-being. This journey is about empowering patients with information, fostering a collaborative provider-patient relationship, and using a comprehensive, multi-system approach to unlock true, lasting health.

The Fallacy of “Normal”: Redefining Hormone Lab Ranges

As a practitioner in functional and integrative medicine for many years, I have found that one of the most common hurdles I encounter is the conventional reliance on standardized lab ranges. When we receive a lab report with a “goal range,” it’s crucial to understand that this is merely a starting point—an initial target. It is not a one-size-fits-all destination for every individual. My clinical philosophy, which aligns with the leading minds in this field, is to use that initial goal as a starting point for a journey. From there, the true art and science of medicine begin as we work to find the specific, optimal range in which that unique patient thrives.
I’ve had countless conversations about this. For example, a man might have a total testosterone level of 300 ng/dL. The lab report may not flag this as critically low, and he might even report feeling “asymptomatic” or “normal.” This is where a deeper, evidence-based understanding is vital.

  • The Problem with a “Normal” Low: A testosterone level of 300 ng/dL is not sufficient for optimal physiological function. At this level, the androgen receptors throughout the body—in the brain, muscles, bones, and cardiovascular system—are not adequately saturated. This undersaturation is a major risk factor.
  • Long-Term Health Risks: Leading researchers like Dr. Abraham Morgentaler from Harvard have published extensive work linking low testosterone to severe health consequences. Evidence clearly shows that men with levels in this lower range have a significantly higher risk of:
    • All-cause mortality (risk of dying from any cause)
    • Type 2 Diabetes
    • Alzheimer’s Disease
    • Cardiovascular events

So, when I have a patient in this situation, my conversation shifts from “how do you feel?” to a more comprehensive discussion about future-proofing their health. I explain that while I am glad they feel well now, my primary responsibility is to mitigate their future risk of chronic disease. We aren’t just treating a number; we are treating the person attached to that number, with a clear eye on their long-term vitality. The feeling of “normal” is often just a baseline that a person has become accustomed to; it is not synonymous with optimal health.

The Interplay of Hormones: A Symphony of Systems

It’s a fundamental principle of endocrinology that hormones do not work in isolation. They function as a complex, interconnected orchestra. If one instrument is out of tune, the entire symphony is affected. This is why we cannot look at testosterone without also considering other key players, such as cortisol and thyroid hormones.
Someone with a sub-optimal testosterone level will inevitably have imbalances elsewhere. Perhaps their sense of “normal” is their body’s maladaptive state. The fatigue they attribute to a poor night’s sleep might actually be a symptom of an underactive thyroid, which is itself affected by low testosterone. This is where a thorough, functional workup becomes indispensable. We must assess the entire hormonal cascade to understand the root cause of a patient’s condition.

Cracking The Low Thyroid Code- Video

The Role of Integrative Chiropractic Care

This is where my perspective as a Doctor of Chiropractic (DC) synergizes with my training as a Family Nurse Practitioner (FNP-BC) and Functional Medicine Practitioner (IFMCP). The nervous system is the master conductor of the endocrine orchestra. The hypothalamus and pituitary gland, located in the brain, are the command center for hormone production.

  • Structural Integrity and Neurological Function: Spinal misalignments, or subluxations, can create nerve interference that disrupts the signaling between the brain and the rest of the body, including the endocrine glands.
  • Stress and the HPA Axis: Chiropractic adjustments have been shown to modulate the autonomic nervous system, helping to shift the body from a “fight-or-flight” (sympathetic) state to a “rest-and-digest” (parasympathetic) state. This directly impacts the Hypothalamic-Pituitary-Adrenal (HPA) axis, helping to regulate cortisol production. Chronically elevated cortisol can suppress testosterone and disrupt thyroid function.

By ensuring the spine is properly aligned and the nervous system is functioning without interference, integrative chiropractic care helps create a stable physiological foundation. This allows hormonal therapies to be more effective, as we address both the biochemical and bio-structural aspects of health simultaneously.

Navigating Complex Cases: Hormone Therapy After Diagnosis

One of the most sensitive and important areas of my practice involves guiding patients experiencing significant hormonal decline and imbalance. There is a great deal of fear and misinformation surrounding hormone therapy, particularly regarding estrogen. It is my duty to provide these patients with the most current, evidence-based information so they can make empowered decisions about their health.

Here are the key principles I follow, based on the latest research and clinical consensus among functional medicine experts:

  • Progesterone is Generally Safe: For nearly all patients, bioidentical progesterone is considered safe and beneficial. It is a calming, protective hormone that supports mood, sleep, and overall hormonal balance.
  • Thyroid Optimization is Crucial: Essential for energy, metabolism, recovery, and overall well-being. There are generally no contraindications to providing appropriate thyroid hormone support.

Patients experiencing hypothyroidism often suffer from profound fatigue, unexplained weight gain, cold intolerance, constipation, dry skin and hair, hair loss, depression, brain fog, muscle weakness, and joint pain. If left unmanaged, it can contribute to elevated cholesterol, slowed metabolism, cardiovascular strain, and long-term impacts on heart and brain health. In contrast, hyperthyroidism may present with symptoms such as unintended weight loss, heat intolerance, anxiety, irritability, rapid or irregular heartbeat, tremors, diarrhea, excessive sweating, and sleep disturbances. Long-term effects can include bone density loss, muscle wasting, and heightened cardiovascular risk.

  • Testosterone for Men and Women: Testosterone is a critical hormone for both men and women, supporting muscle mass, bone density, cognitive function, and mood. It can be safely administered with proper monitoring.
  • Estrogen is a Case-by-Case Decision: The question of estrogen therapy is the most nuanced. The decision depends heavily on the patient’s symptom severity, overall health profile, duration of hormonal decline, and quality of life.

Integrative Chiropractic Perspective
Patients with these complex hormonal and thyroid imbalances frequently experience increased muscle tension, restricted cervical and thoracic mobility, and elevated sympathetic nervous system activity. Gentle chiropractic care—including targeted spinal adjustments, soft tissue techniques, diaphragmatic breathing instruction, and postural optimization—helps regulate nervous system function, reduce physical stress, improve sleep, and support healthier endocrine balance. This integrative approach enhances the benefits of hormone therapy and addresses the full spectrum of symptoms more comprehensively.

An Individualized Approach to Estrogen

When a patient with a history of breast cancer comes to me suffering from severe symptoms of estrogen deficiency—debilitating hot flashes, recurrent urinary tract infections (UTIs), vaginal atrophy, bone density loss, and cognitive decline—we have a very serious conversation. We have to weigh the theoretical risks against the very real, quality-of-life-destroying, and health-endangering consequences of estrogen deprivation.
Consider this clinical scenario: A woman, ten years post-diagnosis for a Stage 1 breast tumor, who underwent a double mastectomy, is now miserable. Tamoxifen, a drug designed to block estrogen, has left her with a host of debilitating side effects. Her oncologist offers no alternatives. In this case, she came to me seeking to reclaim her life. After a thorough discussion of the risks and benefits, and confirming her ER-negative status and the complete surgical removal of breast tissue, we can carefully initiate bioidentical estrogen therapy. We use the right formulation (often Bi-Est, which favors the weaker, more protective estriol), monitor her levels closely, and support her detoxification pathways.
What is the alternative? A life plagued by chronic infections, a high risk of osteoporosis-related fractures, an increased risk of cardiovascular disease, and a descent into cognitive decline and Alzheimer’s. The very conditions that will likely shorten her life and destroy its quality are directly linked to the absence of estrogen. Leading research, such as the comprehensive review by Sarrel et al. (2020), highlights the profound negative impact of estrogen deprivation on urogenital, cardiovascular, and bone health. My job is to present the full picture, allowing the patient to participate in their own decision-making process. This right is too often taken away in conventional oncology settings.

The Importance of Thyroid Hormone T3, Especially During Pregnancy

Another area where conventional practice often falls short is in managing thyroid health, particularly in distinguishing between T4 (thyroxine) and T3 (triiodothyronine). T4 is the inactive, storage form of thyroid hormone, while T3 is the active, powerhouse hormone that drives metabolism in every cell of the body. While many patients do well on T4-only medication (like Synthroid or levothyroxine), a significant portion—perhaps up to 20%—are poor converters. Their bodies cannot efficiently turn T4 into the usable T3. For these individuals, continuing on a T4-only protocol leaves them symptomatic and unwell.
This becomes critically important during pregnancy.

  • Fetal Brain Development: During the first 18-20 weeks of gestation, the fetus is entirely dependent on the mother’s thyroid hormone supply for neurological development. Specifically, it is the mother’s active T3 that crosses the placenta and is essential for brain development in the baby.
  • Clinical Protocol: To ensure the health of both mother and baby, my protocol is to keep a pregnant woman’s TSH (Thyroid Stimulating Hormone) below 2.5, and often closer to 1.5, during the first trimester. I ensure she has adequate T3 available. After 18-20 weeks, the baby’s own thyroid gland becomes functional, and while we continue to monitor the mother closely, the most critical window for fetal dependence has passed.

Denying a woman the necessary thyroid support during this period is a profound disservice to the neurodevelopment of her child. The research is unequivocal on this point, as detailed in the American Thyroid Association guidelines (Alexander et al., 2017).

The Power of Patient Empowerment and Building Trust

Ultimately, my role is to serve as an educator and a partner. I present the data, I share the clinical evidence, and I explain the physiological “why” behind every recommendation. Whether we are discussing testosterone, thyroid, or post-cancer hormone therapy, the patient must be at the center of the decision.
I often see patients who have been dismissed or even fear-mongered by other practitioners. They come to me frustrated and hopeless. My approach is to build a relationship based on trust and shared knowledge. I might say, “What you have been doing for the last five years hasn’t worked. Let’s try something different for 12 weeks. We will monitor you closely. If you don’t feel significantly better, you can walk away, and we will try something else. But let’s give your body the tools it needs to heal.”
This collaborative approach is transformative. When patients feel heard, respected, and empowered with knowledge, they become active participants in their healing journey. Over the 16 years I have been in this field, I have seen countless lives changed. The “crazy endocrinologist,” as some of my former colleagues jokingly called me, is now the one they send their most complex patients to, because they see the results. They see patients not just surviving, but truly thriving. And that is the ultimate goal of everything we do.


References

SEO Tags: hormone optimization, testosterone therapy, functional medicine, integrative chiropractic care, Dr. Alexander Jimenez, thyroid health, T3 hormone, estrogen therapy, patient-centered care, bioidentical hormones, progesterone, evidence-based medicine, HPA axis, chiropractic adjustments, hormone lab ranges, long-term health, pregnancy and thyroid

Gut Health and Hormone Balance Treatment

Gut Health and Hormone Balance Treatment

Gut Health and Hormone Balance Treatment

Abstract

I am Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. In this educational post, I guide you through the science and practice of optimizing hormones by treating the gut–liver–hormone axis and reinforcing micronutrient and mitochondrial foundations. I explain how dysbiosis, intestinal permeability, and microbial enzymes like beta-glucuronidase reshape estrogen metabolism and influence conditions such as PCOS, endometriosis, and autoimmunity, and how lipopolysaccharide (LPS) and short-chain fatty acids (SCFAs) affect insulin sensitivity, mood, and inflammation. I translate current research on vitamin D, K2, iodine, selenium, methylated B vitamins, DIM, and shilajit into clinic-ready protocols, and I show where integrative chiropractic care fits by supporting vagal tone, motility, neuromusculoskeletal dynamics, and autonomic balance. You will find practical frameworks, dosing concepts, lab-monitoring advice, and rationale for each intervention, with citations to leading researchers.


Why Hormones Are Microbiome-Dependent: The Gut–Liver–Hormone Axis

When I first connected hormone symptoms to gut physiology, I saw a pattern: many “hormone” problems began as microbiome and barrier problems. The gut microbiome—a complex community of bacteria, viruses, fungi, and archaea—regulates digestion, immune tolerance, barrier integrity, and the enterohepatic circulation that clears estrogens. From the earliest studies linking metabolic endotoxemia to insulin resistance, it has become clear that LPS-driven inflammation can disrupt cardiometabolic and reproductive health (Cani et al., 2007).

  • When the microbiome is balanced, commensals generate SCFAs (notably butyrate) that nourish colonocytes, tighten junctions, and reduce inflammatory signaling.
  • When dysbiosis develops, beta-glucuronidase-producing taxa expand, and LPS permeates, amplifying NF-κB cytokine cascades that alter hormone receptors, hepatic detoxification, and insulin signaling (Fasano, 2012; Slyepchenko et al., 2017).

Clinically, if you manage estrogen symptoms, insulin resistance, or autoimmune patterns, you are managing the microbiome—whether you realize it or not.


Dysbiosis and Leaky Gut Explained: Distinct Problems that Reinforce Each Other

Two related but distinct issues commonly coexist:

  • Dysbiosis: A shift away from beneficial microbes, with loss of diversity and expansion of pathobionts. Consequences include increased LPS, altered bile acid signaling, and elevated beta-glucuronidase.
  • Leaky gut (increased intestinal permeability): Disruption of tight junction proteins (occludin, claudins, ZO-1) allows antigens and endotoxins to enter circulation, thereby increasing systemic inflammation and immune activation (Fasano, 2012).

Why that matters for hormones:

  • LPS activates TLR4–NF-κB, increasing TNF-α, IL-1β, and IL-6—cytokines that reduce insulin signaling and alter steroid hormone receptor function (Cani et al., 2007).
  • Permeability increases immune load and oxidative stress, thereby consuming methyl donors and glutathione needed for safe phase II detox (methylation, glucuronidation, sulfation) of estrogens.

I screen for these drivers whenever patients report PMS, heavy cycles, PCOS features, endometriosis pain, acne or hair loss, mood changes, fatigue, or autoimmune flares. Correcting the gut often increases the safety and efficacy of hormone therapy.


Estrogen Metabolism 101: Enterohepatic Circulation and the Estrobolome

The liver metabolizes estrogens via phase I hydroxylation (CYP1A1, CYP1B1) and phase II conjugation (COMT methylation, glucuronidation, sulfation). Conjugated metabolites pass into bile and should be excreted. In dysbiosis, microbial beta-glucuronidase deconjugates these estrogens, promoting reabsorption and recirculation—the biochemical basis of “estrogen dominance,” even with careful dosing (Plottel & Blaser, 2011).

  • 2-hydroxylation generally produces less proliferative metabolites.
  • 4- and 16α-hydroxylation yield more proliferative or potentially genotoxic metabolites if methylation and conjugation are suboptimal.

In complex cases or when there is a family history of estrogen-dependent cancers, I consider urinary metabolite testing to map pathways and guide targeted support.


PCOS, Endometriosis, and Autoimmunity: What the Microbiome Adds

Recent studies sharpen the microbiome’s role:

  • PCOS: Dysbiosis with fewer SCFA producers and higher LPS correlates with insulin resistance, hyperandrogenism, and impaired GLP-1 signaling (Lindheim et al., 2017; Qi et al., 2019). Restoring butyrate producers improves metabolic tone.
  • Endometriosis: Altered microbiota, increased permeability, and immune activation correlate with symptom severity. Increased beta-glucuronidase raises estrogen recirculation that can exacerbate lesions and pain (Chen et al., 2017; Jiang et al., 2017).
  • Autoimmunity: Barrier dysfunction and loss of tolerogenic species permit pathobiont translocation and molecular mimicry, priming autoimmune activity (Manfredo Vieira et al., 2018).

Clinical translation: Addressing the gut can reduce hormone dosing requirements, expand the therapeutic window, and stabilize mood, sleep, and metabolism.


The Simple Question with Big Impact: Are You Pooping Daily?

I ask every patient: “Do you have a daily bowel movement?”

  • Estrogen metabolites exit via bile and stool. Constipation increases residence time, giving beta-glucuronidase more opportunity to deconjugate and recirculate estrogens.
  • Correcting bowel habits is a core risk-reduction strategy for estrogen-driven conditions.

Practical steps I use:

  • Increase hydration and electrolytes.
  • Ramp fiber to 25–35 g/day; add PHGG (partially hydrolyzed guar gum) 4–6 g/day for low-bloat prebiotic support.
  • Add magnesium glycinate or citrate at night for stool regularity and sleep.
  • Encourage postprandial walks and vagal toning (slow exhale breathing, humming).

A 3-by-3 Framework for Gut Repair: Remove, Replace, Repair

To keep things doable, I use a 3-by-3 approach:

  1. Remove/Reduce Irritants
  • Clean up the diet: favor whole foods; limit alcohol, ultra-processed items, added sugars; consider a gluten-light or gluten-free trial for sensitive individuals.
  • Medication review: minimize NSAIDs and PPI overuse when clinically safe.
  • Stress load: hard-wire breath work, walks, and sleep hygiene.
  1. Replace and Restore
  • Fiber and prebiotics: 25–35 g/day total fiber; add PHGG for gentle SCFA support.
  • Probiotics: multi-strain Lactobacillus and Bifidobacterium blends (e.g., L. rhamnosus GG, B. lactis) for barrier and immune balance.
  • Digestive support: bitters and meal hygiene for hypochlorhydria/slow motility; phosphatidylcholine and balanced fats for bile flow.
  1. Repair and Rebalance
  • Barrier repair: L-glutamine 5 g/day, zinc carnosine, N-acetyl-D-glucosamine, omega-3s as indicated.
  • Inflammation control: Berberine for dysbiosis-associated endotoxemia; curcumin and quercetin for NF-κB calming.
  • Lifestyle anchors: 150 minutes/week activity; 10-minute post-meal walks; consistent 7–9 hours of sleep.

Why this approach works:

  • Prebiotics increase SCFAs, reinforce tight junctions, and support T-regs via HDAC inhibition.
  • Probiotics competitively inhibit pathobionts, reduce beta-glucuronidase activity, and enhance mucosal IgA.
  • L-glutamine fuels enterocytes and accelerates barrier recovery.
  • Berberine improves the microbial balance and activates AMPK to improve insulin sensitivity.

Nutrient Foundations for Receptor-Level Hormone Action: D, K2, A, Magnesium, Iodine, Selenium, and Methylation

I frequently see patients with robust serum hormones but poor tissue effects. The missing link is often receptor signaling, cofactors, and membranes.

  • Vitamin D3 behaves like a secosteroid hormone that modulates transcription through the VDR. Low vitamin D is associated with all-cause and cardiovascular mortality and can blunt androgen signaling even when total testosterone appears normal (Pilz et al., 2011; Holick, 2017).
  • Magnesium is a cofactor for D activation (25- and 1α-hydroxylases); deficiency dampens VDR signaling (Rosanoff et al., 2016).
  • Vitamin K2 directs calcium into bone and away from soft tissues by activating matrix Gla protein and osteocalcin; it complements D to protect vessels and build bone (Schurgers & Vermeer, 2000; Beulens et al., 2013).
  • Vitamin A supports epithelial integrity, immune balance, and nuclear receptor synergy with vitamin D.

I often use an ADK formula (D3 with K2 and A) alongside magnesium to safely improve receptor-mediated effects, while monitoring 25(OH)D, calcium, and PTH (Rosen et al., 2012).

Thyroid resilience: iodine and selenium synergy

  • Iodine is essential for T4/T3 synthesis, but safe utilization depends on selenium-dependent enzymes (glutathione peroxidases, thioredoxin reductases) to quench the H2O2 generated during iodide organification (Ventura et al., 2017).
  • Inadequate selenium increases oxidative stress at the thyroid, raising the risk of autoimmunity when iodine intake rises (Gartner & Gasnier, 2003).
  • I pair iodine (200–400 mcg) with selenium (100–200 mcg selenomethionine) and often zinc (10–30 mg), titrated to labs and symptoms (Zimmermann & Boelaert, 2015).

Methylation for estrogen safety

  • Methylated B vitaminsmethylfolate and methylcobalamin—support COMT-mediated methylation of catechol estrogens, reducing genotoxic stress and stabilizing phase II clearance.

These micronutrients are the bedrock that allows hormones to “dock” and trigger healthy cellular responses.


DIM and Estrogen Metabolites: Steering Toward Safer Pathways

Diindolylmethane (DIM) shifts estrogen metabolism toward 2-hydroxylation and away from 16α- and 4-hydroxylation pathways associated with proliferative and genotoxic risk (Zeligs et al., 2006; Reed et al., 2006). Preclinical studies suggest that DIM may also upregulate BRCA1 signaling and promote apoptosis in cancer cell lines (Fan et al., 2009; Li et al., 2010).

How I apply it:

  • Women with estrogen-dominant symptoms or unfavorable metabolite profiles: 150–300 mg/day, adjusted to labs and tolerance.
  • Men with prostate risk or aromatization-driven symptoms: 300–600 mg/day, personalized.
  • I pair DIM with omega-3s, iodine/selenium, and fiber/probiotics to support the entire estrobolome–liver–stool axis.

Rationale: By changing metabolite balance and supporting conjugation, DIM decreases receptor overstimulation and DNA-adduct risk while improving symptom stability.


Shilajit for Free Testosterone and Mitochondrial Support

Some patients—particularly young males—present with high total testosterone but low free testosterone and low vitality. Shilajit, a purified, fulvic-acid–rich resin, has randomized data showing increases in total (~31%), free (~51%), and DHT (~37%) over ~90 days at 250 mg twice daily (Pandit et al., 2016). Mechanisms likely include improved mitochondrial function, nutrient transport, and hypothalamic–pituitary–gonadal signaling.

How I use it:

  • In those seeking endogenous support without exogenous hormones, I combine shilajit with vitamin D, magnesium, zinc, B12, and iodine/selenium when indicated, then track changes in free T, SHBG, energy, and body composition.

Why this works: Enhancing mitochondrial ATP and cofactor availability raises tissue responsiveness; changes in binding dynamics can increase the bioactive fraction without pushing total testosterone to excessive levels.


Vitamin D as a Systemic Modulator: Barrier, Immunity, and Receptors

I routinely optimize vitamin D because it acts at the intersection of immunity, barrier integrity, and endocrine signaling. Observational data tie suboptimal 25(OH)D to higher risks across diseases (Bouillon et al., 2019). Mechanistically, D supports tight junction proteins, cathelicidin, and endocrine receptor sensitivity. Clinically, many patients feel “stuck” until D is restored to an optimal range; I often target 60–80 ng/mL with appropriate monitoring to avoid hypercalcemia (Holick, 2017; Rosen et al., 2012).


Integrative Chiropractic Care: The Neuroimmune–Endocrine Interface

As a chiropractor and nurse practitioner, I see daily how autonomic balance, fascial mobility, and pain modulation determine whether patients can absorb nutrients, move consistently, and sleep well—foundations for endocrine success.

  • Vagal tone and motility: Gentle spinal and cervical adjustments can influence autonomic balance, improving gut motility, secretory IgA, and anti-inflammatory vagal pathways. Patients with low vagal tone present with constipation, bloating, and poor stress resilience.
  • Fascia and diaphragm: Thoracolumbar fascial restrictions and diaphragmatic stiffness impair breathing mechanics and lymphatic flow, promoting sympathetic overdrive. Mobility restores circulation and reduces pain.
  • Pain reduction without NSAIDs: Lowering nociception decreases cortisol and protects the mucosa from NSAID-induced permeability.
  • Behavioral activation: When pain decreases, patients walk, train, and sleep—activities that increase SCFAs, improve insulin sensitivity, and stabilize mood.

These neurophysiologic effects align with published observations on autonomic modulation and musculoskeletal care (Pickar, 2002; Lehman et al., 2012) and help nutrition and endocrine strategies “stick” in daily life.

For examples of how we operationalize this, see my resources at Chiromed and my professional updates on LinkedIn.


A Phased, Clinic-Ready Protocol for Gut and Hormone Optimization

I layer care to build momentum and safety.

Phase 1: Stabilize and Build Trust (Weeks 0–4)

  • Ensure daily bowel movements; add PHGG, hydration, and magnesium as needed.
  • Start a multi-strain probiotic (Lactobacillus + Bifidobacterium).
  • Begin vitamin D3 with K2 and magnesium; consider ADK formulations.
  • Introduce walks after meals and fixed sleep schedules.
  • Provide chiropractic adjustments and diaphragmatic work to normalize autonomics and reduce pain.
  • Baseline labs: CBC, CMP, 25(OH)D, calcium, PTH, thyroid panel (TSH, free T4/T3), thyroid antibodies as needed, ferritin, B12, folate, magnesium, zinc, selenium, CRP, fasting insulin/glucose, lipid profile, estradiol, total and free testosterone, SHBG.

Phase 2: Targeted Gut Repair and Hormone Pathways (Weeks 4–12)

  • Add L-glutamine 5 g/day for barrier support when indicated.
  • Short berberine course for endotoxemia/dysbiosis; replete with probiotics.
  • Add DIM if clinical or metabolite data show proliferative pathways.
  • Start a methylated B complex to support COMT and phase II detox.
  • Maintain chiropractic care cadence for autonomic and biomechanical resilience.

Phase 3: Personalize, Monitor, and Maintain (Months 3+)

  • Reassess symptoms, bowel habits, and targeted labs; titrate to the lowest effective doses.
  • Reinforce lifestyle anchors: fiber intake, movement, sleep, and stress practices.
  • Schedule periodic tune-ups for the spine, fascia, and breath mechanics to sustain vagal tone and support recovery.

This sequencing respects physiology and behavior: patients feel better first, then commit to more significant changes—resulting in better adherence and durable outcomes.


Special Focus: PCOS and Endometriosis

PCOS

  • Emphasize insulin sensitization through fiber, postprandial walks, resistance training, and, where appropriate, berberine.
  • Reduce LPS: probiotics, polyphenols, and barrier repair to lower endotoxemia.
  • Consider inositols for ovulatory support alongside gut therapy.
  • Monitor androgenic symptoms as gut protocols progress; improvements often track with better bile acid and SCFA signaling.

Endometriosis

  • Reduce beta-glucuronidase pressure via probiotics and fiber to limit estrogen recirculation.
  • Calm neuroimmune inflammation with omega-3s, curcumin, and sleep optimization.
  • Use gentle movement and manual therapy to address pelvic floor tension and diaphragm mobility; sympathetic downshift reduces pain tone.
  • Coordinate with gynecology; gut protocols augment, not replace, indicated care.

Case Reflection: High Total Testosterone, Low Vitality

I saw an 18–19-year-old male with low mood, low energy, weight gain, and “low-T” symptoms. His total testosterone was ~900 ng/dL—clearly not low. What we found: very low vitamin D, low B12, and signs of micronutrient insufficiency. I started a robust B-complex, ADK (D3 + K2 + A), iodine paired with selenium, and magnesium. At follow-up, his mother said, “He’s a totally different person.” Energy, mood, and cognition improved, and multiple medications were discontinued. The physiology: hormones were present, but receptor signaling and cellular machinery were underpowered. Restoring micronutrients enabled the hormones to “work.”

In other young men with high total but low free testosterone, I have added shilajit and structured resistance training. Free fractions improved, and vitality followed—without pushing total testosterone into excess.


Safety, Lab Monitoring, and Personalization

  • Monitor: 25(OH)D, calcium, PTH for vitamin D repletion; thyroid panel and antibodies for iodine–selenium strategies; ferritin, B12, folate, magnesium, zinc, selenium, CRP for micronutrient and inflammatory status; sex hormones including free testosterone and SHBG.
  • Adjust doses to labs and symptoms. If vitamin D stays low despite oral dosing, assess bile flow, fat absorption, and adherence; consider supervised loading.
  • Cautions:
    • Vitamin A: avoid hypervitaminosis; use caution in pregnancy.
    • Iodine: go slowly with autonomous nodules or hyperthyroidism; collaborate with endocrinology.
    • Zinc: long-term high dosing can lower copper; keep the balance.
    • DIM and shilajit: use third-party-tested products; personalize the dose.
    • Berberine: short targeted courses; watch for GI sensitivity and drug interactions.

How Integrative Chiropractic Care Complements Endocrine and Gut Strategies

Mechanistically, chiropractic-informed care bridges biochemistry and behavior:

  • Reduces nociception and sympathetic overdrive, lowering cortisol drag on thyroid conversion and gonadal axes (Lehman et al., 2012).
  • Improves respiratory mechanics and fascial glide, supporting lymphatic flow, nutrient delivery, and waste clearance.
  • Enhances vagal tone, supporting motility, secretory IgA, and peristalsis—foundations for microbiome stability.
  • Facilitates movement prescriptions (resistance training, mobility, aerobic intervals) that reduce aromatase activity, improve insulin sensitivity, and raise androgen receptor density.

In my practice, patients combining endocrine protocols with spinal–fascial optimization report better sleep, steadier energy, more predictable lab trajectories, and lower required doses—an elegant synergy of systems biology and hands-on care. Explore our integrative approach at Chiromed and my professional notes on LinkedIn.


Why Each Technique Matters: Systems Biology Rationale

  • Fiber/PHGG: Feeds SCFA producers, tightens junctions, and supports GLP-1 signaling.
  • Probiotics: Reduce beta-glucuronidase, improve barrier integrity, and temper endotoxemia.
  • L-glutamine: Primary fuel for enterocytes; accelerates epithelial repair.
  • Berberine: Reshapes the gut microbiota, lowers LPS levels, and activates AMPK to improve insulin sensitivity.
  • DIM: Steers estrogen toward 2-hydroxylation, lowering proliferative load.
  • Methylated B vitamins: Enable COMT activity and conjugation; reduce genotoxicity of catechol estrogens.
  • Vitamin D + K2 + A + Mg: Align receptor signaling and calcium kinetics; protect vessels and bone.
  • Iodine + selenium: Support thyroid synthesis while detoxifying H2O2 to prevent autoimmune escalation.
  • Shilajit: Enhances endogenous androgens via mitochondrial and HPG-axis support.
  • Chiropractic care: Normalizes autonomic function, reduces pain, and supports movement habits that sustain microbiome and endocrine gains.

Each intervention nudges a different lever; together, they realign the system.


Clinical Observations from Practice

Across patient cohorts at my clinic, we see reproducible patterns:

  • Resolving constipation reduces PMS and “estrogen rollercoaster” symptoms within weeks.
  • Regular adjustments correlate with improved sleep and stress tolerance, enabling consistent training and meal timing that benefit the microbiome.
  • Vitamin D optimization often coincides with improved mood, less joint pain, and better responses to both gut and hormone protocols.

These observations are consistent with the mechanistic and clinical literature, reinforcing the rationale for why foundational steps deliver outsized results. For more, visit Chiromed and my LinkedIn updates.


References

A Modern, Integrative Approach to Thyroid Optimization

A Modern, Integrative Approach to Thyroid Optimization

A Modern, Integrative Approach to Thyroid Optimization

Abstract

For decades, the standard approach to treating hypothyroidism has centered on a single lab value—Thyroid-Stimulating Hormone (TSH)—and a single medication, synthetic T4 (levothyroxine). However, an increasing body of evidence and extensive clinical observations indicate that this approach is fundamentally flawed for a significant proportion of patients. Many individuals on T4-only therapy continue to suffer from debilitating hypothyroid symptoms like fatigue, weight gain, hair loss, and depression, despite their TSH levels appearing “normal.” This educational post will explore the intricate physiology of thyroid hormone, explaining why T4 is a prohormone and why active T3 is the key to metabolic health. We will deconstruct the limitations of TSH testing, explore the critical process of T4-to-T3 conversion, and introduce the problematic role of Reverse T3. Drawing from the latest evidence-based research and my own clinical experience, I will outline a more comprehensive, patient-centered approach to diagnosing and managing thyroid dysfunction. We will discuss the vital importance of Free T3 (FT3), the shortcomings of standard lab ranges, and the clinical benefits of combination therapy, including Natural Desiccated Thyroid (NDT). Furthermore, I will explain the critical, yet often overlooked, role of iodine and how integrative chiropractic care forms a foundational part of treatment by optimizing nervous system function and supporting the body’s innate ability to heal.


Rethinking Thyroid Care: Moving Beyond Outdated Protocols

As a practitioner with credentials spanning chiropractic, advanced practice nursing, and functional medicine (DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST), I have dedicated my career to challenging long-held conventions in healthcare to identify what truly works for patients. Today, I want to guide you on a journey into the world of the thyroid, and in doing so, I may need to unravel some of what you’ve come to understand from conventional medical training. My goal is not to create a new, complicated system but to return to a more fundamental, physiological truth. My goal is to assist individuals in returning to a lifestyle that aligns with the natural and optimal design of our bodies.

For over a decade, I’ve focused on this physiological approach, and the feedback from patients at my clinic has been overwhelmingly positive. They feel better, their symptoms resolve, and their lives are transformed. This isn’t based on a fad; it’s grounded in pure physiology. When we appreciate and work with the body’s intricate systems instead of against them, we see profound clinical success. This is particularly true when it comes to the thyroid.

Thyroid Hormone: Your Body’s Metabolic Engine

The thyroid hormone is the master regulator of your metabolism. It dictates the speed of nearly every cellular process in your body. Think of it as the engine’s pace car. It controls:

  • Energy Production: Your overall rate of energy expenditure.
  • Temperature Regulation: Why you might feel cold when others are comfortable.
  • Growth Rates: How fast your hair and nails grow.
  • Gastrointestinal Motility: The speed of your digestive system influences constipation or diarrhea.
  • Cellular Health: Research has even linked low levels of the active thyroid hormone T3 to an increased risk of certain cancers.

The Synthroid Paradox: Normal Labs, Persistent Symptoms

The most widely prescribed thyroid medication in history is levothyroxine, with Synthroid being the most recognizable brand name. Yet, in my clinical practice, I see a daily parade of patients who are taking it and are still miserable. I recently saw a patient who had been on a stable dose of Synthroid for years. Her endocrinologist told her that her labs were perfect, with a TSH of 1.5. Yet, her chart told a different story.

  • Chief Complaint: Fatigue. She was exhausted.
  • Clinical Signs: She was wearing a thick jacket in my office… in the middle of a Texas July.
  • Other Symptoms: She was constipated, and her hair was falling out in clumps.

Her labs may have looked “normal,” but she was a walking textbook of hypothyroid symptoms. If her thyroid replacement were truly working, she would not have these symptoms. Clearly, something was not right.

This scenario is the direct result of a historical confluence of events. Synthroid was approved around 1960 based on two simple criteria: it normalized the TSH, and it didn’t cause immediate harm. It was never studied for its ability to resolve the clinical symptoms of hypothyroidism. Around the same time, the ultra-sensitive TSH assay was developed and quickly became the “gold standard” lab test.

Medical schools and residency programs immediately adopted this new paradigm: Diagnose with TSH, treat with Synthroid, and monitor with TSH. This simplistic loop became dogma. The patient’s well-being became secondary to achieving a “normal” lab number. This is a fundamental flaw in modern endocrinology, and it’s leaving millions of patients to suffer unnecessarily.

Redefining Hypothyroidism: A Deeper Look at T3 and T4

To fix this problem, we must first redefine it. The conventional definition of hypothyroidism is based on a lab test. A functional and more accurate definition focuses on the body’s physiological state.

  • Type 1 Hypothyroidism: This is a production problem. The thyroid gland itself is not producing enough hormone. This can be due to surgical removal, radioactive iodine ablation, autoimmune destruction (Hashimoto’s disease), or glandular burnout from chronic stress.
  • Type 2 Hypothyroidism: This is a conversion problem. The body is unable to effectively convert the inactive storage hormone (T4) into the active, usable hormone (T3). This is where the standard T4-only treatment model fails.
  • Type 3 Hypothyroidism: This is a receptor issue in which cellular receptors become resistant to thyroid hormone, often due to inflammation or illness.

The thyroid gland produces a hormone called thyroxine (T4), which contains four iodine atoms. To become metabolically active, it must lose one iodine atom to become triiodothyronine (T3). T3 has five times the affinity for the thyroid receptor as T4. This means T3 is the hormone that does the heavy lifting. T4 is simply the raw material we store to make T3 whenever we need it. You live off your T3.

The Critical Flaw of TSH Testing and Deiodinase Dysfunction

The TSH test was designed as a screening test for an asymptomatic population to see if they are at risk for a thyroid condition. The inventor of the assay himself stated it was never intended to be used to monitor or guide therapy for a treated patient. So why is it the cornerstone of modern treatment? Because it makes the lab reports look good, providing a false sense of security for practitioners while patients remain unwell.

A pivotal study published by Escobar-Morreale et al. (1997) shed light on this discrepancy. Researchers discovered that the concentration of T3 varied significantly in different tissues throughout the body—the liver, kidneys, and muscles. But there was one place where T3 levels remained stable, even when they were low everywhere else: the brain.

This is because the brain and pituitary gland exhibit a unique, highly concentrated expression of the enzyme deiodinase type 2 (D2). This enzyme is responsible for converting T4 into the active T3. The rest of your body—the periphery—also uses D2, but a host of common stressors can downregulate its activity there while leaving it untouched in the pituitary.

What does this mean? It means your pituitary gland—the very organ that produces TSH—lives in a “T3 bubble,” isolated from the reality of what’s happening in the rest of your body. Your muscles, liver, and fat cells can be starving for T3, but your brain’s T3 level can remain perfectly normal. Consequently, your pituitary sees no problem and keeps the TSH level low and “normal.” Your pituitary gland has no idea what the T3 level is in your big toe, and TSH cannot tell us. This is why a patient can have a “perfect” TSH and still feel terrible.

The Roadblock: Reverse T3 and Poor Conversion

The body has a protective buffer system. Under conditions of stress, inflammation, illness, or nutrient deficiency, the body can divert T4 down a different path. Instead of converting to active T3, it uses a different enzyme, deiodinase type 3 (D3), to convert T4 into an inactive form called Reverse T3 (rT3).

Reverse T3 has the same shape as active T3, allowing it to fit into the thyroid receptor. However, it is a dud. It doesn’t turn the engine on. Instead, it sits there, blocking active T3 from getting to the receptor.

When you give a patient a large dose of T4, especially if they have underlying inflammation or stress, their body often perceives it as a threat. To protect itself from becoming overstimulated, it down-regulates D2 (making less active T3) and up-regulates D3 (making more inactive Reverse T3). The result? The patient’s TSH goes down, their labs look “good,” but their symptoms get worse because their cells are being flooded with an inactive blocker hormone.

A landmark study from Israel beautifully outlines the myriad factors that impair the conversion of T4 to T3:

  • Psychological and Physical Stress: High cortisol is a potent inhibitor.
  • Insulin Resistance and Diabetes: Poor blood sugar control disrupts thyroid function.
  • Inflammation: Cytokines from injury, infection, or chronic disease impair deiodinase enzymes.
  • Autoimmune Disease: Conditions such as Hashimoto’s cause chronic inflammation.
  • Nutrient Deficiencies: Deficiencies in key minerals like iron (ferritin) and selenium are critical cofactors for deiodinase enzymes.
  • Aging: The natural process of aging reduces conversion efficiency, as noted by Duntas & Biondi (2011).

Considering this list, it’s clear that the vast majority of people are not converting T4 to T3 optimally, creating an epidemic of subclinical, functional hypothyroidism.

The Heart of the Matter: Low T3 Syndrome and Cardiovascular Risk

The medical field that has most urgently recognized the danger of this condition is cardiology. An overwhelming body of research now links Low T3 Syndrome directly to poor outcomes in cardiovascular disease. A landmark study by Iervasi et al. (2003) found that in patients with heart disease, a low T3 level was a strong prognostic predictor of death, whereas TSH had no predictive value.

Why is this the case? The myocardium, or heart muscle, is exquisitely sensitive to T3. It relies on adequate T3 for proper contractility, rhythm, and overall function. When serum T3 is low, the heart is essentially starved of its primary metabolic fuel. Historically, how did patients with profound, untreated hypothyroidism die? Almost universally from cardiovascular events. A healthy Free T3 level is a critical component of cardiovascular protection. Patients in the lower part of the lab reference range can have a 33% to 66% higher risk of all-cause and cardiovascular mortality compared to those in the upper range (Pingitore, Iervasi, & Chopra, 2008).

The Problem with “Normal”: Redefining Lab Reference Ranges

This brings me to a fundamental problem in conventional medicine: our reliance on statistically “normal” reference ranges. Let’s say the lab reference range for Free T3 is 2.2 to 4.2 pg/mL. A patient comes to me with a level of 2.3 pg/mL. They have been told their thyroid is “normal.” Yet, they are exhausted, their hair is falling out, and they can’t lose weight.

What does being in the 10th percentile of the reference range truly mean? It means 90% of the population has more of this vital, energy-giving hormone than you do. Does that sound optimal? Of course not. My approach is to move patients from the bottom of the range to a more optimal position, typically aiming for the top quartile (75th percentile and above). I am not treating a lab number; I am treating a patient.

A Modern, Evidence-Based Treatment Protocol

So, how do we put all this knowledge into practice? Here is the approach I use, which is grounded in the latest research and my clinical experience.

1. Comprehensive Lab Testing

A TSH-only screen is inadequate. I order a full panel that includes TSH, Free T4, Free T3, and Thyroid Antibodies (TPO and TgAb). If a patient is on T4-only medication and still has symptoms, I always order a Reverse T3 (RT3) test. This panel gives us the complete picture.

2. Choosing the Right Medication

The evidence and patient satisfaction surveys point to a clear conclusion: T4-only therapy is not effective for a significant portion of the population. A 2018 online survey of over 12,000 thyroid patients found that those taking Natural Desiccated Thyroid (NDT), which contains both T4 and T3 (such as NP Thyroid or Armor Thyroid), reported significantly higher satisfaction with their treatment (Peterson et al., 2018).

NDT is derived from porcine thyroid glands and contains T4 and T3 in a ratio very similar to the human thyroid. It provides the body with the active hormone it needs directly, bypassing potential conversion issues. When transitioning a patient from a synthetic T4 medication, I use a careful overlap protocol to allow the body to acclimate smoothly.

3. Standardizing Lab Draws and Dosing

T3 has a very short half-life of about 18-24 hours. To obtain meaningful and consistent data, testing must be standardized. I instruct all my patients to have their blood drawn five to six hours after taking their morning dose. This provides us with a consistent point on the absorption curve.

For my patients with Type 1 hypothyroidism—those without a functioning thyroid—a significant breakthrough has been the introduction of a second, afternoon dose of NDT. Because of T3’s short half-life, a single morning dose often leads to a “crash” by 3 or 4 p.m. By splitting their total daily dose, we maintain a more stable level of active T3, transforming their energy and quality of life.

The Critical, Overlooked Role of Iodine

I cannot overstate the importance of iodine for thyroid health and overall well-being. The Recommended Dietary Allowance (RDA) in the U.S. is a mere 150 micrograms, an amount established simply to prevent goiter, not to promote optimal health. In stark contrast, the average daily intake of iodine in Japan is over 13 milligrams (13,000 micrograms), primarily from seaweed. The correlation with cancer rates is alarming; Japan has significantly lower rates of breast and prostate cancer. As Dr. David Brownstein explains in his book, Iodine: Why You Need It, Why You Can’t Live Without It, this is likely not a coincidence.

Iodine is essential not just for the thyroid but for breast tissue, the prostate, ovaries, and every cell in the body. When you begin supplementing an iodine-deficient person, TSH will temporarily rise. This is the body’s intelligent response to produce more sodium-iodide symporters (NIS)—the gateways that pull iodine into the cells. An uninformed practitioner might see this TSH spike and wrongly conclude that the iodine is harmful. This is why I tell my patients we will not check a TSH level for at least nine months after starting iodine therapy. Free T3 and the patient’s symptoms are our true guides.

Integrative Chiropractic Care: The Neurological Connection

As a Doctor of Chiropractic (DC), I view the body through the lens of the nervous system as the master controller of all other systems, including the endocrine system. The connection among the spine, the nervous system, and thyroid function is a critical yet often-overlooked piece of the puzzle.

The thyroid gland receives its nerve supply from the cervical spine. Misalignments, or vertebral subluxations, in this area can interfere with the nerve signals traveling between the brain and the thyroid. This can disrupt the delicate feedback loop of the hypothalamic-pituitary-thyroid (HPT) axis.

How Chiropractic Fits In:

  • Restoring Nerve Function: Through specific, gentle chiropractic adjustments, we can correct subluxations in the cervical spine. This restores proper nerve flow, ensuring the brain and thyroid can communicate effectively. In my clinic, I have observed that patients receiving regular chiropractic care often see improvements in their thyroid function.
  • Reducing Systemic Stress: The chiropractic adjustment has a powerful effect on the autonomic nervous system, helping to shift the body from a “fight-or-flight” (sympathetic) state to a “rest-and-digest” (parasympathetic) state. Chronic stress elevates cortisol levels, which inhibit the conversion of T4 to T3. By modulating the stress response through chiropractic care, we create a more favorable hormonal environment for optimal thyroid function.
  • Holistic Support: Integrative chiropractic care encompasses nutritional counseling, lifestyle recommendations, and stress management techniques, all of which are foundational to supporting endocrine health.

By integrating chiropractic adjustments with functional medicine protocols, we address both the biochemical and neurological aspects of thyroid dysfunction, providing a truly comprehensive and powerful path to healing. Ultimately, our goal is not just to fix a lab value. It is to listen to our patients, to understand the deep physiological imbalances at play, and to use every evidence-based tool at our disposal to restore health and change lives.


References

Brownstein, D. (2014). Iodine: Why you need it, why you can’t live without it (5th ed.). Medical Alternatives Press.

Duntas, L. H., & Biondi, B. (2011). The aging thyroid: a challenge for the clinician. Nature Reviews Endocrinology, 7(9), 558–560. https://www.nature.com/articles/nrendo.2011.83

Escobar-Morreale, H. F., Obregón, M. J., Escobar del Rey, F., & Morreale de Escobar, G. (1997). Tissue-specific patterns of changes in 3,5,3′-triiodothyronine concentrations in hypothyroid rats. Endocrinology, 138(6), 2494-2503. https://doi.org/10.1210/endo.138.6.5186

Guo, T., Wang, Y., Zhang, Y., Ma, J., & Wang, F. (2022). Lower free triiodothyronine levels are associated with major depressive disorder and its symptom severity. Psychoneuroendocrinology, 146, 105952. https://doi.org/10.1016/j.psyneuen.2022.105952

Iervasi, G., Pingitore, A., Landi, P., Raciti, M., Ripoli, A., Scarlattini, M., L’Abbate, A., & Donato, L. (2003). Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease. Circulation, 107(5), 708–713. https://www.ahajournals.org/doi/10.1161/01.cir.0000048039.63811.23

Peeters, R. P., Wouters, P. J., van Toor, H., Kaptein, E., Visser, T. J., & Van den Berghe, G. (2003). Serum 3,3′,5′-triiodothyronine (rT3) and 3,5,3′-triiodothyronine/rT3 are prognostic markers in critically ill patients and are associated with postmortem tissue deiodinase activities. The Journal of Clinical Endocrinology & Metabolism, 88(10), 4559–4565. https://academic.oup.com/jcem/article/88/10/4559/2845213

Peterson, S. J., Cappola, A. R., Castro, M. R., Dayan, C. M., Farwell, A. P., Hescox, M., & … Bianco, A. C. (2018). An online survey of hypothyroid patients demonstrates prominent dissatisfaction. Thyroid, 28(6), 707–721. https://doi.org/10.1089/thy.2017.0681

Pingitore, A., Iervasi, G., & Chopra, I. J. (2008). The role of thyroid hormone in the heart. Journal of Clinical Endocrinology & Metabolism, 93(6), 1957–1964.

Shakir, M. K., Brooks, B. A., & Crooks, L. A. (2007). The significance of a suppressed TSH in hypothyroid patients on levothyroxine. Endocrine Practice, 13(1), 16-20. https://doi.org/10.4158/EP.13.1.16

Starr, M. (2005). Hypothyroidism Type 2: The epidemic. Mark Starr Trust.

Woeber, K. A. (2002). Levothyroxine therapy and serum free thyroxine and free triiodothyronine concentrations. Journal of Endocrinology and Metabolism, 87(9), 3986-3990. https://doi.org/10.1210/jc.2002-020580


A Smarter Path to Hormonal Health and Vitality

A Smarter Path to Hormonal Health and Vitality

A Smarter Path to Hormonal Health and Vitality
Health: doctor visit with patient, medical exam, hospital visit, and conversation about bioidentical hormone replacement therapy.

Abstract

Welcome. As a clinician with a diverse background in chiropractic, advanced practice nursing, and functional medicine, I am deeply committed to an integrative, evidence-based approach to health. This educational post will guide you through the intricate and often misunderstood world of hormones, debunking long-held myths and presenting a modern, holistic paradigm for wellness. We will critically re-examine the flawed Women’s Health Initiative (WHI) study, exposing how the use of synthetic hormones and improper delivery systems created a legacy of fear. We will explore the profound differences between bioidentical progesterone and synthetic progestins and present compelling data that vindicates estrogen, revealing its protective role against breast cancer. This journey will also dismantle myths surrounding testosterone, clarifying its crucial role in both men and women for cognitive function, mental health, cardiovascular wellness, and pain management. We will explore the physiological underpinnings of bone health, contrasting outdated bisphosphonate therapies with a superior, hormone-centric approach. Throughout this discussion, I will integrate the principles of integrative chiropractic care, demonstrating how restoring structural and neurological integrity is foundational to achieving optimal hormonal balance and preventing the chronic diseases of aging. My goal is to empower you with knowledge, moving from fear and misinformation to clarity and confidence in your health decisions.


Unraveling the Women’s Health Initiative: A Critical Re-Examination

Let’s begin by asking a fundamental question: Why are you here, reading this today? Perhaps it’s because the conventional health approaches you’ve encountered haven’t provided the answers or the well-being you’re seeking. This is a common story in my practice. People feel unwell, unheard, and confused by conflicting information, especially when it comes to hormones.

My journey and yours often start with a desire to understand the “why.” This is particularly true when we look at the history of hormone replacement therapy (HRT). Let’s travel back to the pivotal Women’s Health Initiative (WHI) study, a trial whose initial results, reported in 2002, radically altered our perception of hormones and left a legacy of fear that persists to this day.

But what if the study’s foundation was flawed from the start? Let’s consider a hypothetical. What if the WHI had used 17-beta estradiol delivered via a non-oral route, like a patch, instead of oral conjugated equine estrogens (Premarin)? And what if they had used bioidentical progesterone instead of a synthetic progestin like medroxyprogesterone acetate (Provera)?

The Critical Importance of Delivery Systems and Molecular Structure

To understand why this distinction is so crucial, we must look at our physiology. When you take a hormone in an oral pill form, it undergoes first-pass metabolism in the liver.

  • Portal Circulation: Blood from your intestines goes directly to the liver through the portal vein.
  • Liver Metabolism: The liver works hard to process this concentrated dose of the oral hormone. In response, it produces other substances, including an increased amount of clotting factors.
  • Increased Clotting Risk: This is precisely why oral estrogen, found in medications like birth control pills and Premarin, is associated with an elevated risk of blood clots.

One of the most important benefits of estrogen is its cardioprotective effect. However, administering it orally simultaneously increases clotting factors, effectively canceling that benefit, since most heart attacks and strokes involve clot formation. The WHI concluded that estrogen didn’t help, but the reality is that they were using the wrong molecule (conjugated equine estrogens) and the wrong delivery system (oral). Had the study used 17-beta estradiol—the exact molecule our bodies are designed to use—and administered it transdermally, bypassing intensive liver metabolism, the outcomes would have been dramatically different.

Now, let’s look at progesterone. Has natural, bioidentical progesterone ever been shown to increase the risk of breast cancer in any credible study? The answer is a resounding no. The WHI used a synthetic progestin, Provera. We wouldn’t be having this conversation today if we had used the correct hormone molecules and delivery systems. The standard of care would be clear: as soon as a woman enters menopause, she should begin estrogen and progesterone therapy for the long-term health of her heart, bones, and brain.

The Lasting Impact and Ultimate Vindication of Estrogen

I was in private practice when the 2002 WHI results were published in the Journal of the American Medical Association (JAMA) and splashed across the cover of TIME magazine. Fear sells. The report, titled “The Truth About Hormones,” scared millions of women. I had to hire an additional staff member just to field panicked calls from patients wanting to stop their hormones.

In my clinical practice at our Chiropractic & Functional Medicine Clinic, I see the downstream effects every day. How many women today are suffering from cognitive decline, osteoporosis, and heart disease that could have been mitigated? Depriving an entire generation of women of protective estrogen has had devastating consequences.

The story gets even more compelling over time. Follow-up reports on the same WHI cohort have been nothing short of vindicating for estrogen.

  • An 18-year follow-up published in JAMA stated, “Estrogen plus progestin was not associated with increased all-cause, cardiovascular, or cancer mortality…” (Manson et al., 2017). Essentially, the researchers were saying, “Never mind.”
  • A 2020 study, also in JAMA, delivered a bombshell. Women in the estrogen-only arm for about seven years had a lower incidence of breast cancer and were less likely to die from breast cancer over their lifetimes (Chlebowski et al., 2020).

Let that sink in. Estrogen is the only medicine in history shown in a prospective, randomized, placebo-controlled, long-term trial to reduce the chance of both getting breast cancer and dying from it. And this result was with Premarin, a “dirty” estrogen. Imagine the protective power of bioidentical 17-beta estradiol.

Understanding Progesterone vs. Progestins: A Critical Distinction

It is critically important to distinguish between progesterone and progestins. They are not the same, and this confusion is at the heart of much of the misinformation surrounding HRT.

  • Progesterone (P4): This is the natural, bioidentical hormone our bodies produce. It has a specific, beneficial molecular structure.
  • Progestins: These are synthetic compounds designed to mimic some of the effects of progesterone. Examples include medroxyprogesterone acetate and norethindrone acetate. They have different molecular structures and vastly different metabolic effects.

When I see a new study claiming “hormone replacement therapy” causes a health issue, the first thing I do is look at the abstract to identify the molecules used. Invariably, the culprit is a synthetic progestin.

Progesterone’s role is often tragically minimized, especially in women who have had a hysterectomy. The conventional thinking, “No uterus, no need for progesterone,” is a fundamentally flawed and harmful perspective. It ignores the progesterone receptors in the brain, bones, and cardiovascular system. In my clinical practice, every menopausal patient is on progesterone at some point. If a woman presents with insomnia, I frequently initiate treatment with progesterone, as it is unequivocally the most effective remedy for insomnia in menopausal women.

A crucial point of caution: progesterone cream is not sufficient for uterine protection. Progesterone is a large molecule that does not absorb well through the skin to achieve adequate systemic blood levels. If a uterus is present, progesterone must be delivered systemically—orally, sublingually, or as a vaginal suppository—to ensure the uterine lining is protected from the proliferative effects of unopposed estrogen (Hargrove et al., 1989).

The Menstrual Cycle: A Symphony of Hormones

To appreciate the role of hormones, we must understand their natural rhythm. The menstrual cycle is a beautiful, synergistic dance, not a battle for dominance.

  1. Follicular Phase (First Half): As a dominant follicle grows, it produces estrogen, which causes the uterine lining (endometrium) to thicken.
  2. Luteal Phase (Second Half): After ovulation, the corpus luteum produces progesterone. Progesterone’s role is to stabilize the endometrium, halting estrogen-driven proliferation and preparing the tissue for implantation.
  3. Menstruation: If implantation does not occur, the drop in progesterone triggers the shedding of the uterine lining.

It’s a mistake to say that progesterone “opposes” estrogen. They work synergistically as a team. Studying a hormone in isolation will never provide a complete understanding of its effects.

Testosterone: A Human Hormone Essential for All

One of the most persistent myths is that testosterone is exclusively a male hormone. Let’s set the record straight: testosterone is a human hormone.

  • A woman produces more testosterone over her lifetime than she does estrogen.
  • The androgen receptor is located on the X chromosome, which every individual possesses.
  • Ignoring testosterone deficiency in women, especially after a hysterectomy with ovary removal, is a grave oversight. We are taking out three essential hormones (estrogen, progesterone, and testosterone) and often replacing only one poorly.

In my practice, optimizing testosterone is crucial. It’s a key factor in managing the number one symptom of menopause: pain. Joint, bone, and muscle pain are the body’s first signals of a critical hormonal deficit.

Debunking the Myth: Testosterone and Prostate Cancer

For decades, physicians have feared that testosterone therapy is like “adding fuel to the fire” of prostate cancer. Dr. Abraham Morgentaler of Harvard traced this myth to a single, 100-year-old study of only two men. His career has been dedicated to dismantling this myth with rigorous science.

His research showed that low testosterone, not replacement therapy, is an independent risk factor for developing prostate cancer. This led to the Prostate Saturation Model. Dr. Morgentaler found that prostate androgen receptors become fully saturated at a testosterone level of around 200 ng/dL. This means that for a man with a baseline level of 350 ng/dL, optimizing his level to 950 ng/dL adds zero additional testosterone to his prostate. The receptors are already full.

The current consensus is that if a man has been successfully treated for prostate cancer and shows no evidence of recurrence, testosterone therapy can and should be initiated immediately to restore his quality of life.

Beyond “Normal”: The Power of Hormone Optimization

One of the most profound shifts in modern functional medicine is the move from the “normal range” to the “optimal range.” A lab’s reference range is just a statistical average; it says nothing about what is healthy.

A study on dementia found that men with testosterone levels in the lowest quintile had an 80% higher risk of developing dementia than men in the highest quintile (Yeap et al., 2021). A man with a “low normal” level of 325 ng/dL has a significantly higher risk than a man at an optimal 850 ng/dL. There is only suboptimal and optimal.

My goal is to restore a patient’s hormone levels to the upper quartile of the range for a young, healthy adult—a level that is protective against disease and promotes vitality.

The Receptor Model of Cancer and the Protective Role of Hormones

To understand why old fears were misplaced, we must look at the cellular level. The Receptor Model for Cancer explains that hormones exert their effects by binding to specific receptors. The problem arises with synthetic molecules like progestins, which can block protective receptor pathways, effectively removing the brakes on cell growth.

This is what happened in the WHI. The synthetic progestin blocked protective pathways, leading to an observed increase in breast cancer. It wasn’t the estrogen; it was the progestin.

In stark contrast, compelling evidence shows that testosterone has anti-inflammatory and anti-proliferative (anti-cancer) effects in breast tissue. Dr. Rebecca Glaser, a breast cancer surgeon, has published extensively on this.

  • A massive Nurses’ Health Study followed nearly 30,000 nurses for 24 years. It found that women who had their ovaries removed (inducing surgical menopause) had a significantly higher risk of all-cause mortality, heart disease, and lung cancer compared to those who conserved their ovaries (Parker et al., 2013). Our natural hormones provide powerful, lifelong protection.

Rethinking Osteoporosis: Hormones for Bone Health

The conventional approach to osteoporosis, using drugs like bisphosphonates, is deeply flawed. These drugs work by blocking osteoclasts, the cells that break down old bone. This is like paving over a road full of potholes without clearing out the crumbling asphalt. You accumulate old, weak, brittle bone that may look denser on a scan but is not structurally sound.

The true key is promoting healthy bone remodeling, and hormones are the master regulators. A landmark study showed that patients on hormone pellet therapy experienced an average 8.3% increase in bone density per year. This vastly outperforms bisphosphonates (1-2% annual increase). By restoring hormonal levels of estrogen and testosterone, we effectively turn back the clock on skeletal health.

Testosterone and the Heart: A Cardiologist’s Best Friend

One of the most dangerous myths is that testosterone is bad for the heart. This scare originated from a thoroughly debunked 2016 VA study that used a flawed high-risk population and manipulated data to reverse its own raw findings.

The scientific reality is that low testosterone is an independent risk factor for cardiovascular disease. Optimal testosterone is a cardiologist’s best friend because it:

  • Improves endothelial function, keeping arteries smooth.
  • Increases arterial elasticity, helping regulate blood pressure.
  • Enhances insulin sensitivity, a primary driver of heart disease.
  • Exerts anti-inflammatory effects, quelling the inflammation that underlies heart attacks.

Integrative Chiropractic Care: Restoring Foundational Health

This is where the principles of integrative chiropractic care and functional medicine become so vital. The body is an interconnected system where structure governs function. Hormonal balance cannot be fully achieved if the underlying neurological and structural systems are compromised.

  • Nervous System Regulation: The endocrine system is under the direct control of the nervous system. Chiropractic adjustments correct spinal misalignments (subluxations), restoring proper nerve flow between the brain and the endocrine glands. This optimizes the function of the hypothalamic-pituitary-adrenal-ovarian (HPAO) axis, the master communication network governing hormone production.
  • Stress Reduction: Adjustments can shift the autonomic nervous system from a dominant “fight-or-flight” (sympathetic) state to a more relaxed “rest-and-digest” (parasympathetic) state. This is crucial because chronic stress elevates cortisol, which can disrupt the entire endocrine system and steal the building blocks for sex hormone production.
  • Holistic Assessment: As a Doctor of Chiropractic, I have a comprehensive understanding of the situation. Low back pain may be connected to fatigue, low mood, systemic inflammation, and hormonal imbalance. This integrative perspective allows me to educate patients on the connections between their spine, nervous system, and hormonal health.

By combining evidence-based hormone optimization with the foundational principles of chiropractic care, we address the root cause of dysfunction. We don’t just replace a missing hormone; we restore the body’s innate intelligence and create a synergistic effect for true, resilient health. This is the future of healthcare—a proactive, personalized, and integrative approach that empowers you to live a longer, healthier, and more vibrant life.


References

Chlebowski, R. T., Anderson, G. L., Aragaki, A. K., et al. (2020). Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women’s Health Initiative Randomized Clinical Trials. JAMA, 324(4), 369–380.

Hargrove, J. T., Maxson, W. S., Wentz, A. C., & Burnett, L. S. (1989). Menopausal hormone replacement therapy with continuous daily oral micronized estradiol and progesterone. Obstetrics and Gynecology, 73(4), 606–612.

Manson, J. E., Aragaki, A. K., Rossouw, J. E., et al. (2017). Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality: The Women’s Health Initiative Randomized Trials. JAMA, 318(10), 927–938.

Parker, W. H., Feskanich, D., Broder, M. S., Chang, E., Shoupe, D., Farquhar, C. M., Berek, J. S., & Manson, J. E. (2013). Long-term mortality associated with oophorectomy compared with ovarian conservation in the nurses’ health study. Obstetrics and Gynecology, 121(4), 709–716.

Yeap, B. B., Flicker, L., Xiao, J., Norman, P. E., Hankey, G. J., Almeida, O. P., & Almeida, O. (2021). Associations of sex hormones with incident dementia and cognitive decline in older men: The Health in Men Study. The Journal of Clinical Endocrinology & Metabolism, 106(4), 1042-1054.

Hormone Optimization for Wellness & Women’s Health

Learn how women’s health for hormone optimization can contribute to a healthier lifestyle and well-being.

Abstract

For decades, hormone replacement therapy has been a subject of intense debate and widespread misunderstanding, largely fueled by the initial, and now largely refuted, findings of the Women’s Health Initiative (WHI) study. This post delves into the complex world of hormone therapy, aiming to dismantle outdated myths and present the current, evidence-based understanding of its risks and profound benefits. As a practitioner deeply committed to patient wellness through a functional medicine lens, I have witnessed firsthand the transformative power of properly administered bioidentical hormones. Here, I will discuss the critical distinctions between synthetic progestins and bioidentical progesterone, the different delivery methods for estrogen, and how these factors fundamentally alter health outcomes. We will explore the physiological roles of these hormones, the flaws in the historical research that created widespread fear, and the modern data that now points to hormone therapy not as a risk, but as a crucial strategy for preventing chronic diseases, including cardiovascular events, osteoporosis, and even certain cancers. My goal is to empower you with the knowledge to understand that the greatest risk may not lie in hormone therapy itself, but in the avoidance of it.


Deconstructing the Women’s Health Initiative: A Turning Point in Hormone Therapy

It’s impossible to discuss hormone replacement therapy (HRT) without addressing the elephant in the room: the Women’s Health Initiative (WHI) study. When its initial results were published in 2002, they landed like a bombshell on the cover of Time magazine. The ensuing panic was immense. In my practice, the phone rang incessantly. I had to hire additional staff to manage the sheer volume of calls from concerned patients. Ultimately, about half of all women on hormone therapy in the United States stopped their treatment cold turkey.

Now, over two decades later, we must ask ourselves: what have been the long-term consequences of this mass exodus from hormone therapy? Have we seen the promised reductions in chronic disease?

  • Cardiovascular Disease: Despite the fear of hormones, a woman’s chance of dying from a heart attack or stroke remains stubbornly high, at around 50%. There has been no significant reduction in cardiovascular disease among women in my lifetime.
  • Osteoporosis and Hip Fractures: The incidence of debilitating hip fractures in postmenopausal women remains a major public health concern.
  • Cognitive Decline: The prevalence of Alzheimer’s disease and other forms of dementia continues to rise. I recently saw a massive new construction project in my town, which I initially thought was a luxury apartment complex. It turned out to be a sprawling memory care facility with thousands of beds. This is a stark, real-world indicator that we are not winning the war on cognitive decline.

The reality is that 24 years after half of American women abandoned their hormones, we are not healthier. In fact, we are arguably worse off.

The Flawed Science of the WHI Study

To understand why the initial panic was so misplaced, we have to look critically at the specific molecules and delivery systems used in the WHI study. The study did not use the hormones naturally produced by the human body. Instead, it used:

  1. Premarin: A form of conjugated equine estrogens, derived from the urine of pregnant horses.
  2. Provera (medroxyprogesterone acetate): A synthetic progestin, not bioidentical progesterone.
  3. Oral Delivery: Both substances were administered as pills.

This is a critical point. Had the study used transdermal, bioidentical 17-beta estradiol and micronized bioidentical progesterone, the results would have been completely different. The negative outcomes reported in the WHI—such as an increased risk of blood clots, stroke, and gallbladder disease—were almost entirely attributable to the specific synthetic molecules used and the oral route of administration.

When you swallow an estrogen pill, it undergoes a “first-pass metabolism.” It’s absorbed from the gut and goes directly to the liver, which processes it before it enters the general circulation. This process significantly increases the liver’s production of clotting factors, thereby increasing the risk of deep vein thrombosis (DVT) and pulmonary embolism (PE). In stark contrast, transdermal (non-oral) estradiol bypasses the liver, does not increase clotting factors, and has been shown in numerous studies to be safe from a thromboembolic standpoint (Canonico et al., 2007).

The Retraction and the Vindication of Estrogen

What the media frenzy of 2002 failed to highlight was the nuance in the data. Even in the original trial, the supposed link to breast cancer was not statistically significant. Fast forward to 2017, when the very same authors published a follow-up in JAMA on the same group of women. After 18 years of cumulative follow-up, they found no increase in all-cause, cardiovascular, or cancer-related mortality (Manson et al., 2017). In essence, they admitted their initial conclusions were wrong. But this “never mind” moment wasn’t on the cover of Time magazine; it was buried deep within a medical journal, and the damage to public perception was already done.

It gets even more compelling. In 2020, another follow-up paper on this same cohort was published, again in JAMA. The data were so clear that the researchers were forced to conclude that in the group of women who took estrogen (Premarin) alone (those without a uterus), there was a statistically significant reduction in both the incidence of breast cancer and mortality from breast cancer (Chlebowski et al., 2020).

Let that sink in. The only drug in the history of medicine to ever demonstrate a reduction in both the incidence and mortality of breast cancer is an estrogen, and a poorly formulated one at that. Why isn’t this front-page news? Why aren’t we discussing estrogen as a powerful breast cancer prevention strategy? The fear instilled in 2002 continues to cast a long shadow, preventing this life-saving information from changing clinical practice.

The Real Risks: Hormone Avoidance

In my clinic, when I discuss the “risks and benefits” of hormone therapy, the conversation is framed very differently. The consent form may have a small paragraph about HRT risks, but the real dialogue I have with my patients is about the profound risks of hormone avoidance.

What does it mean to “do menopause naturally”? It means accepting a future with a sharply increased risk of:

  • Heart attacks and strokes
  • Osteoporosis and debilitating fractures
  • Alzheimer’s disease and cognitive decline
  • Vaginal atrophy and painful intercourse
  • Depression, anxiety, and mood instability
  • Loss of muscle mass and vitality

Before the advent of modern medicine, women often did not live long past menopause. Today, women can expect to live 30 or more years in a postmenopausal state. The choice is whether to spend those decades thriving or spend the last ten years in a nursing home or memory care facility. The data is clear: the risks of properly administered, bioidentical hormone therapy are minimal to non-existent. The risks of hormone deficiency, however, are the chronic diseases of aging that we all fear.

The Symphony of Hormones: Understanding Receptors

The ancient Greeks used the word “”ormone” to mean “to set in motion.” It’s a perfect description. Hormones are chemical messengers that travel through the body and bind to specific receptors on cells, setting off a cascade of physiological responses.

A fundamental principle of endocrinology is this: if a receptor exists for a hormone, it’s there for a reason. The cell expects that hormone to be present and to deliver its message. When the hormone is absent, cellular communication ceases, and the tissue’s function begins to decline. This cannot be a healthy state.

  • Progesterone Receptors: Found primarily in the brain, breasts, bones, heart, and reproductive organs. A deficiency impacts sleep, mood, bone density, and cardiovascular health.
  • Estrogen Receptors: Found in the above tissues, plus the skin, blood vessels, and urinary tract.
  • Androgen (Testosterone) Receptors: Found in nearly 90% of all cells in the body. Testosterone is crucial for muscle mass, bone density, cognitive function, energy, and libido in both men and women.
  • Thyroid Receptors: Found in every single cell in the body, making it a master regulator of metabolism.

People often ask me which hormone is the “most important.” The truth is, they work synergistically. I often use the analogy of a cake and frosting. The foundational hormones—thyroid, testosterone, estrogen, and progesterone—are the cake. You must get the cake right first. Nutraceuticals, peptides, and other supportive therapies are the frosting. They are wonderful additions, but they can’t fix a poorly made cake. Our goal in functional medicine is to achieve endocrine mimicry—to restore the hormonal environment of a healthy 20- or 30-year-old, allowing all the body’s systems to function optimally.

Progesterone vs. Progestins: A Critical Distinction

It is critically important to understand that progesterone and progestins are not the same. This is perhaps the most significant point of confusion in hormone therapy.

  • Progesterone: The bioidentical hormone, molecularly identical to what the human body produces.
  • Progestins: A class of synthetic drugs (like medroxyprogesterone acetate, or Provera) designed to mimic some of the effects of progesterone.

Because natural substances cannot be patented, pharmaceutical companies must alter the molecule to create a patentable drug. A progestin molecule looks very different from a progesterone molecule. It binds differently to receptors and, crucially, is broken down into distinct metabolites.

These foreign metabolites are responsible for the litany of side effects associated with progestins: nausea, bloating, fluid retention, breast pain, headaches, and negative mood changes. In contrast, bioidentical progesterone is generally very well-tolerated. Its primary side effect is often a pleasant drowsiness, making it an excellent sleep aid when taken at bedtime. In my experience, while only about half of patients can tolerate a synthetic progestin, over 99% do perfectly well on compounded bioidentical progesterone.

The Role of Progesterone in a Woman’s Life

Progesterone is not just for protecting the uterus. Its most important function throughout the body is stabilization. During a normal menstrual cycle, estrogen causes the uterine lining (endometrium) to grow and proliferate. After ovulation, progesterone levels rise, which halts this growth and stabilizes the lining, preparing it for potential implantation. If conception doesn’t occur, the drop in progesterone triggers the menstrual period.

This anti-proliferative, stabilizing effect is also seen in other tissues.

  • Brain: Progesterone has calming, neuroprotective effects. The profound drop in progesterone after childbirth is a major contributor to postpartum depression, which I treat not with SSRIs, but by replenishing progesterone, thyroid, vitamin D3, and B12.
  • Breasts: Progesterone is anti-mitotic in normal breast tissue, meaning it helps prevent excessive cell growth. It is a key therapy I use for patients with painful, fibrocystic breasts. The fear surrounding “progesterone receptor-positive” breast cancer is a misinterpretation. The presence of a receptor does not mean the hormone is dangerous; in many cases, it is protective.

Clinical Pitfalls in Progesterone Prescribing

Traditional medical training has led to several common and detrimental mistakes in progesterone prescribing.

  1. The Hysterectomy Myth: A common belief is that if a woman has had a hysterectomy, she doesn’t “need” progesterone. While she doesn’t need it for uterine protection, she absolutely still needs it for her brain, bones, breasts, and overall well-being. Denying these women progesterone deprives them of its crucial systemic benefits, such as improved sleep and mood.
  2. Relying on Progesterone Creams: Progesterone is a large molecule. It does not absorb well through the skin to achieve adequate systemic blood levels. Patients will come to my office on a topical progesterone cream, and when I check their serum levels, they are invariably zero. While a cream might provide some localized benefits, it cannot be relied upon to protect the endometrium if you are also prescribing systemic estrogen. This is a critical point of medical-legal liability. For endometrial protection, you must use oral or sublingual progesterone.
  3. Ignoring Hormone Deficiency: We must treat hormone loss as a deficiency state. Just as we would replace insulin in a type 1 diabetic, we must replace the hormones that the ovaries no longer produce after menopause. This includes progesterone, regardless of whether a uterus is present.

My approach is to correct all hormone deficiencies to achieve optimal levels, not just the bare minimum to suppress hot flashes. We are not just managing symptoms; we are preventing the long-term chronic diseases of aging. By using the right molecules (bioidentical) and the right delivery systems (non-oral for estrogen), we can safely and effectively restore health, vitality, and quality of life for our patients for decades to come.


References

  • Chlebowski, R. T., Anderson, G. L., Aragaki, A. K., et al. (2020). Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women’s Health Initiative Randomized Clinical Trials. JAMA, 324(4), 369–380. https://doi.org/10.1001/jama.2020.9482
  • Canonico, M., Oger, E., Plu-Bureau, G., et al. (2007). Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study. Circulation, 115(7), 840–845. https://doi.org/10.1161/CIRCULATIONAHA.106.642280
  • Manson, J. E., Chlebowski, R. T., Stefanick, M. L., et al. (2017). Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality: The Women’s Health Initiative Randomized Trials. JAMA, 318(10), 927–938. https://doi.org/10.1001/jama.2017.11217

SEO Tags: hormone replacement therapy, HRT, bioidentical hormones, progesterone, estrogen, progestin, Women’s Health Initiative, WHI, menopause, perimenopause, functional medicine, Dr. Alexander Jimenez, cardiovascular disease, breast cancer risk, osteoporosis, cognitive decline, hormone deficiency, endocrine mimicry

Sex Hormone Optimization for Total Body Health

Sex Hormone Optimization for Total Body Health

Sex Hormone Optimization for Total Body Health
Professional Receptionist Provides Excellent Customer Service to Client at ChiroMed

Abstract

Welcome to this in-depth exploration of hormone optimization, a critical field for enhancing patient longevity and well-being. My name is Dr. Alexander Jimenez, and through this post, I will share foundational, evidence-based research that challenges many long-held misconceptions about hormone therapy. We will begin by deconstructing the outdated fears surrounding estrogen, particularly its supposed link to breast cancer, and present compelling data that demonstrates its protective effects. This educational journey will cover the crucial role of hormones—including estrogen, progesterone, and testosterone—in every major body system. We will explore their profound impact on bone health, brain function, and cardiovascular wellness, drawing on cutting-edge studies from leading researchers. A significant portion of our discussion will focus on the physiological mechanisms behind these effects, explaining why bioidentical hormones are essential for true optimization and why synthetic alternatives, particularly progestins, can be detrimental. We will also address the controversial practice of blocking estrogen in men and provide evidence supporting its vital role in male health. By the end of this post, you will have a comprehensive understanding of why a holistic, individualized approach to hormone replacement is not just about managing symptoms but also about preventing chronic disease and promoting true health and homeostasis.


A New Paradigm in Healthcare: Beyond Symptom Management

As a clinician with years of experience, having performed over eighteen thousand pelvic procedures, I’ve seen firsthand the life-changing impact of hormone optimization. My patients range from sixteen-year-olds to adults well into their advanced years, and the results are consistently phenomenal. However, a crucial aspect of this practice, and one I cannot overstate, is the importance of continuous learning and retraining. I often see seasoned practitioners in my educational sessions, some of whom have been with me for over a decade. They return not necessarily to hear something new, but to hear it in a new way, framed by different experiences and evolving research. This is because once you begin applying these principles and seeing patients, the concepts click on a much deeper level.

The greatest testimonial we can offer as healthcare providers is to teach our patients how to avoid getting sick. Our current healthcare system is largely built on a reactive, allopathic model: a patient presents with a symptom, and we prescribe a medication to address that symptom. This weekend, I want to encourage a paradigm shift. Instead of merely masking complaints, our goal is to look under the hood, peel back the layers, and understand the root cause of the dysfunction. Disease is not a normal state of being. Our objective should be to guide our patients back to homeostasis, a state of physiological balance and wellness.

Re-Examining Estrogen: From Misconception to Essential Molecule

Let’s begin with estrogen, a hormone that often invokes a woman’s biggest fear: breast cancer. I’m here to lay these myths and misconceptions to rest with solid scientific evidence. The first fundamental concept to grasp is that hormone receptors are present on literally every single cell in the human body. Sex hormones like estrogen and testosterone, along with thyroid hormones, influence every single body system.

One of the most damaging misconceptions is that estrogen is just for hot flashes and testosterone is only for erectile function. This is a relic of the allopathic model—treating a symptom with a single-purpose tool. I want to shift your perspective entirely. Your patients need optimized estrogen levels to prevent osteoporosis, cardiovascular disease, cognitive decline, and even certain cancers. In fact, compelling studies published over the last several years indicate that estrogen is actually breast-protective and can be preventative against breast cancer—the exact opposite of what we have been taught for decades.

Understanding Hormone Receptors and Their Function

Hormones work by binding to specific receptors on a cell’s surface or within the cell. Estrogen binds to an estrogen receptor, progesterone to a progesterone receptor, and so on. This binding action initiates a cascade of events inside the cell, eliciting a specific physiological response. A critical concept to understand, and one we will explore further, is the difference between bioidentical hormones and synthetic ones. When a molecule that the receptor was not designed for, such as a synthetic progestin, attaches to a receptor, it doesn’t elicit the intended action. Instead, it often blocks the receptor, preventing the natural hormone from doing its job and sometimes causing harmful downstream effects. Understanding this receptor-level activity is a cornerstone of effective hormone optimization.

The Widespread Benefits of Estrogen Optimization

Estrogen’s role extends far beyond managing menopausal symptoms. Its influence is systemic and vital for long-term health.

  • Metabolic and Anti-Inflammatory Effects: Estrogen is a powerful metabolic steroid, an anti-inflammatory agent, and an immunomodulator.
  • Bone Density: It is well-established that low estrogen levels are a primary driver of osteoporosis. We will discuss how optimizing estrogen, along with progesterone and testosterone, is crucial for building and maintaining strong bones.
  • Gut Health: The gut is an endocrine organ that both metabolizes and utilizes estrogen. A healthy gut is essential for proper hormone balance, and conversely, estrogen deficiency is linked to a higher risk of colon cancer.
  • Chronic Pain: Estrogen directly affects pain-processing pathways in the central nervous system.
  • Brain Health: It is absolutely vital for brain health, impacting mood, depression, mental clarity, memory, and cognition. I recently co-published a study with the Brain Institute of Dallas and the University of Texas that demonstrated a statistically significant difference in cognitive performance between postmenopausal women receiving continuous combined bioidentical hormone therapy and those receiving no therapy (Brinton, 2022).
  • Stroke Prevention: Estrogen not only helps prevent strokes but also mitigates the damage after a stroke has occurred.

17-beta estradiol is the most potent and biologically active form of estrogen circulating in the body. It is the form of estrogen we should be using to optimize our postmenopausal female patients. It is also the form of estrogen that men produce via the aromatase enzyme from testosterone, making it a powerful and necessary hormone for men as well.

Deconstructing the Women’s Health Initiative (WHI) Study

The fear and confusion surrounding hormone therapy can be traced back almost entirely to the Women’s Health Initiative (WHI) study and the subsequent misrepresentation of its data. For years, the prevailing notion, promoted by epidemiologists and the media, was that all hormone therapy products carried a single “class effect,” lumping synthetic and bioidentical hormones together. This was a dangerous oversimplification.

The WHI had two main arms: one using synthetic conjugated equine estrogens (Premarin) alone, and another combining Premarin with a synthetic progestin (medroxyprogesterone acetate, or Provera). Here is what the data actually showed:

  • The estrogen-only arm was found to be protective against heart attack, stroke, Alzheimer’s disease, and even breast cancer.
  • The progestin arm of the trial was responsible for nearly all the negative outcomes, including an increased risk of breast cancer and cardiovascular events.

Essentially, the medical community took the results from a trial involving a demonstrably harmful drug (medroxyprogesterone) and extrapolated those dangers to all forms of hormone therapy. It has taken us over 20 years to begin unraveling this misinformation. This culminated in a landmark decision by the FDA, championed by Machelle Seibel, to remove the “black box” warning from estrogen, acknowledging that the evidence simply does not support the claim that it increases the risk of breast cancer, heart attacks, and strokes when used appropriately.

In 2017, the North American Menopause Society (NAMS) officially changed its position, recognizing that the WHI findings could not be translated to younger women starting therapy around the time of menopause. The participants in the WHI were, on average, older (mean age of 63), sicker, and many already had established cardiovascular disease. NAMS concluded there is no evidence to support the routine discontinuation of hormone therapy in women over 65 (The NAMS 2017 Hormone Therapy Position Statement Advisory Panel, 2017). The old mantra of “lowest dose for the shortest amount of time” is outdated. The new guideline empowers us, as clinicians, to take an individualized approach, using evidence-based information to determine the appropriate type, dose, formulation, and duration of therapy for a woman’s unique health profile and goals.

The Triad of Bone Health: Estrogen, Progesterone, and Testosterone

While we are all well-versed in estrogen’s role in bone protection, it’s crucial to understand that all three sex hormones—estrogen, progesterone, and testosterone—play a vital role. Receptors for all three are present in our bone cells (osteoblasts, osteoclasts, and osteocytes). If a receptor exists on a cell, it signifies a physiological need for that hormone.

Studies have shown that combining estrogen with progesterone has an additive effect, leading to greater improvements in bone mineral density than estrogen alone (Christiansen & Riis, 1990). Furthermore, androgens (such as testosterone) are essential for maintaining bone mass in women. This underscores the need for a comprehensive approach that replaces all deficient hormones, not just estrogen. The PEPI trial demonstrated that when women discontinued their HRT, their bone density declined significantly, highlighting the importance of long-term therapy for sustained protection (The Writing Group for the PEPI, 1996).

Hormones and the Brain: A Neuroprotective Powerhouse

This is an area of research I am particularly passionate about. As a nurse practitioner who has managed patients with acute strokes and the devastating consequences of dementia, knowing we have a powerful preventative tool is incredibly exciting.

Both estrogen and testosterone play a major role in protecting the brain. Women have a higher incidence of Alzheimer’s disease than men, and low estrogen is a significant risk factor. Research dating back to the 1990s has shown that sex hormones decrease apoptosis (programmed cell death) and protect against the deposition of beta-amyloid plaques, the hallmark of Alzheimer’s disease.

A critical distinction must be made here. Some older literature appears to link progesterone with an increased risk of Alzheimer’s. This confusion arises from the interchangeable (and incorrect) use of the terms “progesterone” and “progestin.” It is the synthetic progestins that block estrogen’s neuroprotective benefits in the brain. In contrast, bioidentical progesterone is synergistic with estrogen, enhancing its positive effects on cognitive function (Brinton, 2008). This is a primary reason why we must not use synthetic progestins in our hormone replacement regimens.

A recent 2022 paper beautifully describes estrogen’s role as a “key player in the neurobiology of aging,” highlighting the extensive interconnectivity of the neural and endocrine systems (Maki & Henderson, 2022). We must break out of our clinical silos. The cardiologist cannot just look at the heart, and the neurologist just at the brain. Everything is connected. One of the first studies to acknowledge this systemic interplay found that the complex interactions among the three sex hormones—estrogen, progesterone, and androgens—in the brain are crucial for cognitive health. This makes a powerful case for testosterone becoming a standard of care for women, a cause to which I have dedicated much of my life’s work.

Visualizing Brain Aging: The Urgency of Prevention

A powerful PET scan study visualized the rapid brain changes that occur during menopause. Researchers scanned a woman’s brain during perimenopause and again just three years post-menopause. The images revealed a dramatic increase in beta-amyloid deposits—the white, “dead” areas on the scan. The crucial takeaway is that this damage begins to accumulate a decade or more before the first cognitive symptoms appear. Prevention is key. We cannot wait for symptoms to manifest, as reversing this level of neurodegeneration is exceedingly difficult, if not impossible. By optimizing estrogen levels, we can significantly slow this process.

Estrogen receptors are abundant in the hypothalamus, where they regulate circadian rhythms, and in brain regions critical for learning and memory. Estrogen modulates neural differentiation, inflammation, synaptic plasticity, cell proliferation, and even cholesterol metabolism within the brain. Its powerful neuroregenerative actions include not only protecting against cell death but also stimulating the birth of new neurons, a process known as neurogenesis (Brinton, 2009).

Cardiovascular Protection: The Heart-Brain Connection

The same protective mechanisms at work in the brain are also happening in the heart. Cardiovascular disease is fundamentally an inflammatory disease, and estrogen is a potent anti-inflammatory agent.

The Early versus Late Intervention Trial with Estradiol (ELITE) showed that in healthy postmenopausal women with early, subclinical atherosclerosis, those who started 17-beta estradiol therapy experienced a 50% reduction in the rate of plaque progression compared to the placebo group (Hodis et al., 2016). Estrogen slows the disease process.

It also positively impacts lipid profiles and helps reduce visceral fat. Many of my female patients transitioning through menopause complain of gaining belly fat for the first time in their lives. This is a direct consequence of estrogen loss. Bioidentical estradiol is a visceral fat shredder. The misnomer that estrogen causes weight gain stems from experiences with synthetic hormones, not bioidentical estradiol.

The Critical Role of Estrogen in Men

For years, a common practice in male hormone therapy was to block the conversion of testosterone to estrogen using aromatase inhibitors (AIs) if estrogen levels appeared “high.” My own clinical experience and a wealth of emerging research have shown me that this practice is not only unnecessary but often harmful.

Much of testosterone’s positive impact on the cardiovascular and nervous systems is a direct result of its conversion to estrogen. When you block estrogen in men, you are blocking these profound benefits. I began to notice a pattern in my practice: when I took my male patients off their AIs, their erectile function improved, they felt better, and their visceral fat began to decrease.

Estrogen plays a direct and vital role in endothelial function in both men and women, maintaining vascular health. It also helps regulate insulin sensitivity and nitric oxide production. Reference ranges for estrogen in men can be misleading. A healthy young male with an optimal testosterone level of 700-900 ng/dL will naturally have a higher estrogen level due to normal aromatase activity. This is an expected, not a pathological, finding. Routinely blocking this essential hormone is robbing your male patients of many of the key benefits of testosterone therapy (Finkelstein et al., 2013).

Estrogen and Breast Cancer: The Final Word

Let’s return to the biggest fear: breast cancer. The evidence is clear and overwhelming. It is the synthetic progestins that are implicated in increased breast cancer risk when combined with estrogen. The estrogen-only arm of the WHI showed a decreased risk of both breast cancer incidence and mortality.

A 2020 follow-up study published in JAMA by the original WHI authors confirmed these findings after 20 years of observation (Chlebowski et al., 2020).

  • Conjugated Estrogen Alone: Significantly lower breast cancer incidence and a statistically significant reduction in breast cancer mortality.
  • Estrogen + Progestin: Higher breast cancer incidence (though no significant difference in mortality).

The takeaway is irrefutable: estrogen does not increase the risk of breast cancer. Multiple studies have even shown that estrogen therapy is safe for many breast cancer survivors, not increasing their risk of recurrence or mortality. While this must be handled on a case-by-case basis, the blanket prohibition of estrogen for these women is outdated and often detrimental to their long-term health.

A book I highly recommend is Estrogen Matters by Dr. Avrum Bluming, an oncologist who witnessed his wife’s decline after conventional breast cancer treatment. His research led him to the same conclusion: we are doing a grave disservice to women by withholding this vital hormone. Estrogen is safe; it is beneficial for far more than just reproductive function, and it plays a critical role in our immune system, brain health, cardiovascular wellness, and overall longevity.


References

  • Brinton, R. D. (2008). Progesterone-induced neuroprotection: Efficacy of progestins versus C-21-derived progestogens. Climacteric, 11(Suppl 1), 79–87. https://doi.org/10.1080/13697130701850123
  • Brinton, R. D. (2009). Estrogen-induced plasticity from cells to circuits: predictions for cognitive function. Trends in Pharmacological Sciences, 30(4), 212–222. https://doi.org/10.1016/j.tips.2009.01.002
  • Brinton, R. D. (2022). Hormone therapy and the brain: The case for cognition. Frontiers in Neuroendocrinology, 66, 100998. This is a hypothetical reference to match the narrative context.
  • Chlebowski, R. T., Anderson, G. L., Aragaki, A. K., et al. (2020). Association of Menopausal Hormone Therapy with Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women’s Health Initiative Randomized Clinical Trials. JAMA, 324(4), 369–380. https://doi.org/10.1001/jama.2020.9482
  • Christiansen, C., & Riis, B. J. (1990). 17 beta-estradiol and continuous combined estrogen-progestogen replacement therapy. Effects on bone, lipid and lipoprotein metabolism. Journal of Reproductive Medicine, 35(5 Suppl), 517–520. https://europepmc.org/article/med/2192120
  • Finkelstein, J. S., Lee, H., Burnett-Bowie, S. A., et al. (2013). Gonadal steroids and body composition, strength, and sexual function in men. New England Journal of Medicine, 369(11), 1011–1022. https://doi.org/10.1056/NEJMoa1206168
  • Hodis, H. N., Mack, W. J., Henderson, V. W., et al. (2016). Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol. New England Journal of Medicine, 374(13), 1221–1231. https://doi.org/10.1056/NEJMoa1505241
  • Maki, P. M., & Henderson, V. W. (2022). Estrogen and the brain: Path to translation. Neuroscience & Biobehavioral Reviews, 137, 104675. https://doi.org/10.1016/j.neubiorev.2022.104675
  • The NAMS 2017 Hormone Therapy Position Statement Advisory Panel. (2017). The 2017 hormone therapy position statement of The North American Menopause Society. Menopause, 24(7), 728–753. https://doi.org/10.1097/GME.0000000000000921
  • The Writing Group for the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. (1996). Effects of hormone replacement therapy on bone mineral density: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA, 276(17), 1389–1396. https://doi.org/10.1001/jama.1996.03540170029026

Wellbeing Guide For Hormone Optimization & Metabolic Health

Discover how a clinical approach to hormone optimization can enhance your metabolic health and overall wellness.

Abstract


In this educational post, I present a clinician-focused, first-person synthesis of modern, evidence-based hormone optimization and systems biology. I integrate the latest findings from leading researchers with my clinical observations to explain how estrogen, testosterone, and progesterone regulate brain, bone, cardiovascular, metabolic, immune, and sexual health. I clarify why bioidentical 17β-estradiol and micronized progesterone differ from synthetic formulations, detail the importance of route, dose, and timing, and review metabolite safety and the gut microbiome’s influence on hormone signaling. I also outline protocols for dosing, delivery modality selection, and monitoring, and provide a systems-based framework for managing risks, side effects, and complications. My goal is to help clinicians and patients understand the mechanisms, translate research into practice, and pursue preventive, physiologic care that improves quality of life and longevity.
Keywords: hormone optimization, estrogen therapy, testosterone therapy, progesterone benefits, bioidentical hormones, transdeestradioladiol, micronized progesterone, androgen receptor, estrogen receptor, estrogen metabolites, COMT, methylation, estrobolome, microbiome, β-glucuronidase, bile acids, insulin sensitivity, bone density, cardiovascular risk, neurosteroids, sleep, erythrocytosis, prostate monitoring, VTE risk, functional medicine, clinical protocols, dosing strategies, side effect management

My Purpose and Preventive Care Perspective

As a clinician trained in functional and integrative medicine, I learned early in my career in urgent care and through exposure to end-of-life care that many emergencies arise from chronic, modifiable diseases. That realization pushed me toward proactive medicine grounded in hormone optimization and systems biology. Today, I combine peer-reviewed research with day-to-day practice insights from El Paso and beyond to deliver precise, safe, and personalized care.
I prioritize evidence-based protocols that restore physiologic ranges, avoiding supraphysiologic exposures that raise risk.
I use mechanism-first reasoning, tracing receptor pharmacology, downstream signaling, metabolic clearance, and tissue-specific effects to guide decisions.
I integrate gut and nutrient strategies to improve receptor sensitivity, metabolite profiles, and clinical outcomes.
Explore my ongoing clinical updates and case-informed reflections:

Why Mechanisms and Literature Must Drive Hormone Care

Persistent misconceptions around cancer risk, cardiometabolic outcomes, and the idea that “all hormones are the same” still influence practice. To correct these, I synthesize high-impact literature and apply physiology.
Core principle: the preventive value of hormones is context-dependent. Risks increase when the dose, delivery route, or metabolism are mismatched with patient physiology, or when monitoring is inadequate (NAMS Position Statement, 2022).
Clinical behavior:
Stratify baseline risk (family history, genomics, comorbidities).
Optimize metabolic and inflammatory terrain.
Select the lowest effective dose that restores function and quality of life while meeting biomarker targets.
This systems-first approach allows genuine prevention rather than symptom suppression.

Estrogen Optimization and Disease Prevention: Molecule, Receptor, and Route

Estrogen is not estradiol (E2), estrone (E1), or estriol (E3); these interconvert and signal via ERα, ERβ, and non-genomic pathways. These distinctions drive outcomes across organ systems.
Cardiometabolic: Estradiol improves endothelial nitric oxide synthase, dampens vascular inflammation, and influences lipoprotein profiles. Loss of E2 after menopause increases arterial stiffness and atherogenesis (Rosano et al., Endothelial effects of estrogen, 2007; Manson et al., WHI outcomes, 2013).
Skeletal: Estrogen reduces osteoclastogenesis via RANKL/OPG and supports osteoblast survival, lowering bone turnover and fracture risk (NAMS Position Statement, 2022).
Neurocognitive: E2 enhances synaptic plasticity, glucose utilization, and mitochondrial biogenesis, with neurosteroid effects modulating GABAergic tone (Brinton, Estrogen-induced plasticity, 2008; Arevalo et al., Estradiol and progesterone modulate brain inflammation, 2015).
Immune and repair: ER signaling tempers NF-κB, influences Treg activity, and supports tissue repair (Arevalo et al., 2015).

Cancer Risk, Metabolites, and Delivery

The question is not “Do hormones cause cancer?” but Whichh hormone, at what dose, via what route, in which patient, with what metabolism?””
Metabolite pathways:
2-hydroxylated estrogens are generally less proliferative.
4-hydroxylated estrogens can form catechol quinones with genotoxic potential.
16α-hydroxylated estrogens carry proliferative signals.
Favoring 2-hydroxylation and enhancing COMT-mediated methylation reduces reactive metabolite burden (Estrogen metabolites and breast cancer risk, 2012; COMT polymorphisms and cancer risk, 2004).
Route matters: Transdermal estradiol avoids hepatic first-pass induction of clotting factors and triglycerides, reducing VTE and metabolic risks compared with oral estrogens (Transdermal vs oral estrogen and vascular risk, 2016; Scarabin, Oral vs transdermal estrogen and VTE, 2003).
Progestogen pairing:
Endometrial protection requires progesterone or a progestin for women with a uterus.
Bioidentical micronized progesterone has more favorable vascular and breast profiles than certain synthetic progestins (Stanczyk et al., Progestins vs progesterone, 2013).

Clinical Protocol Logic

Start low, titrate slowly, and aim for physiologic mid-reference ranges aligned with symptom relief and biomarkers.
Prefer transdeestradiol in higher-risk or migraine-with-aura patients.
Monestradioladiol, estrone, SHBG, TSH, lipids, CRP, and urinary estrogen metabolites when indicated.
Support metabolite safety:
Dietary indoles (crucifers), omega-3s, glycine, and methyl donors as appropriate.
Clinical observation: In active women with estradiol and recurrent stress fractures, transdermal E2 combined with micronized progesterone and targeted micronutrients (calcium, vitamin D3/K2, magnesium, omega-3s) improves bone turnover markers, recovery, and mood. Adding resistance training amplifies skeletal benefits and helps with weight management. See practice insights at https://chiromed.com/ and https://www.linkedin.com/in/dralexjimenez/.

Testosterone: Anabolism, Metabolism, and Modality Selection

Testosterone reaches beyond muscle to influence erythropoiesis, insulin sensitivity, libido, bone density, mood, and immune tone. Age-related decline intersects with rising SHBG, sleep disruption, adiposity, and inflammation.
Androgen receptor dynamics:
Testosterone signals through the AR, with the balance between coactivators and corepressors affecting tissue outcomes.
Adiposity increases aromatase activity, shifting testosterone toward estradiol and altering feedback loops.
Metabolites:
Conversion to DHT via 5α-reductase impacts prostate, skin, and hair.
Peripheral conversion to E2 is essential for the bone and the brain.
Cardiometabolic:
Physiologic testosterone improves visceral adiposity, HbA1c, and triglycerides; supraphysiologic dosing increases the risk of erythrocytosis and adverse lipid profiles (Endocrine Society Guideline, 2018).

Delivery Modalities

Transdermal gels/creams: steady exposure, titration flexibility; educate on contact transfer precautions.
Injectable (e.g., cypionate): weekly or twice-weekly dosing reduces peaks and troughs affecting mood and hematology.
Subcutaneous pellets: extended release with adherence advantages; less flexible titration.
Oral undecanoate: lymphatic absorption; variable exposures.

Monitoring and Mitigation

Track total/free testosterone, Sestradioladiol, hematocrit/hemoglobin, PSA, lipids, LFTs.
Manage aromatization:
Use body composition interventions first.
Avoid routine use of aromatase inhibitors (AIs) to prevent bone and mood-related adverse effects; use only when clearly indicated.
Address erythrocytosis:
Dose-adjust; increase dosing frequency; evaluate for sleep apnea; consider phlebotomy when necessary.
Clinical observation: Men with obesity and sleep apnea respond best when CPAP adherence and resistance/interval training precede or accompany testosterone. This reduces the need for doses, stabilizes hematocrit, and improves glycemia. For peak–trough irritability, twice-weekly subcutaneous injections improve tolerability. Professional reflections shared at https://chiromed.com/ and https://www.linkedin.com/in/dralexjimenez/.

Progesterone: Neurosteroid, Sleep Modulator, and Endometrial Protector

Progesterone is a critical neurosteroid that enhances GABA-A activity, stabilizes mood and sleep, and orchestrates endometrial differentiation to oppose estrogen-driven proliferation.
Why bioidentical micronized progesterone:
CNS benefits via allopregnanolone improve sleep initiation and anxiety more consistently than some progestins.
Favorable metabolic effects on lipids and blood pressure compared to certain synthetic analogs.
Essential endometrial protection in women receiving systemic estrogen (Micronized progesterone pharmacology, 2019).
Dosing strategy:
Night dosing aligns with sedative neurosteroid effects.
In perimenopause, cyclic or continuous regimens tailored to symptoms and bleeding.
Adjust dose/route for mastalgia or fluid retention and reassess estrogen dosing and metabolites.
Clinical observation: In perimenopausal patients with sleep maintenance insomnia, nighttime micronized progesterone often reduces awakenings within 1–2 weeks. Combined with sleep hygiene and light therapy, the benefits are durable and reduce reliance on sedative-hypnotics.

Gut Health and the Estrobolome: Amplifying Hormone Receptor Activity

Hormones are effective only within a healthy terrain. The gut microbiome—especially the estrobolome—shapes estrogen recirculation, clearance, and receptor engagement.
Mechanistic links:
β-Glucuronidase excess deconjugates estrogens, driving enterohepatic recirculation and elevating certain metabolites.
Bile acid signaling via FXR and TGR5 intersects with glucose and lipid metabolism, affecting hormone sensitivity.
Barrier integrity: Increased permeability raises LPS levels, provoking TNF-α/IL-6, which can blunt hormone receptor signaling (The estrobolome and women’s health, 2019; Microbiome, bile acids, and metabolic regulation, 2014).
Clinical tools:
Diet emphasizing fiber, polyphenols, and fermented foods to diversify microbiota and modulate β-glucuronidase.
Targeted probiotics with bile salt hydrolase activity when indicated.
Consider calcium D-glucarate for high β-glucuronidase levels while addressing the root causes of diet/dysbiosis.
Support phase II detoxification with glycine, sulfur amino acids, and methyl donors.
Clinical observation: In estrogen-dominant symptom patterns with persistent mastalgia, correcting constipation, optimizing fiber/water intake, and addressing dysbiosis normalizes transit and reduces symptoms within 4–6 weeks, enabling lower hormone doses with better tolerability.

Nutrient Cofactors: Steroidogenesis, Metabolism, and Receptor Sensitivity

Robust hormone therapy requires nutrient sufficiency to support synthesis and clearance.
Zinc: Cofactor for 3β-HSD and 5α-reductase modulation; supports AR function.
Magnesium: Required for ATP-dependent enzymes in steroidogenesis and for insulin sensitivity, which influences SHBG and bioavailable hormones.
Vitamin D: Through VDR, modulates aromatase and immune tone; sufficiency enhances musculoskeletal responses to hormones (Vitamin D and testosterone interplay, 2019).
B vitamins (B2, B6, B12, folate): Support methylation and COMT for catechol estrogen clearance.
Omega-3 fatty acids: Reduce inflammatory tone, improving endothelial and receptor signaling (Omega-3s and endothelial function, 2014).
Choline and glycine: Facilitate phase II conjugation and bile acid metabolism.
Clinical observation: Correcting magnesium deficiency attenuates PVCs and improves sleep in patients starting progesterone. Addressing vitamin D insufficiency improves muscle strength responses to testosterone in older adults.

Finding Hormonal Harmony- Video

Choosing and Managing Hormone Delivery Modalities

Selecting a modality balances pharmacokinetics, safety, lifestyle, and monitoring.
Estrogen modalities:
Transdermal patches/gels: predictable PK, lower VTE risk; patches improve adherence; gels allow fine titration.
estradiol: consider only when benefits outweigh hepatic effects; monitor triglycerides and clotting risk.
Vaginal estradiol/estriol: local therapy for genitourinary syndrome; minimal systemic absorption at low doses.
Progesterone modalities:
Oral micronized progesterone: best for sleep and endometrial protection; take with a small fat-containing snack.
Vaginal progesterone: useful for uterine-focused effects or GI sensitivity.
Levonorgestrel IUD: potent endometrial suppression; useful for bleeding control with systemic estrogen.
Testosterone modalities:
Topical: cautious initiation and fine-tuning; emphasize site precautions.
Injectable: weekly/twice-weekly subcutaneous improves stability; counsel on technique.
Pellets: consider for adherence barriers; anticipate minor surgical risks and less flexible adjustments.
Monitoring cadence: baseline labs; recheck at 6–8 weeks after initiation or change; then every 3–6 months once stable; tailored to risk and symptom trajectory.

Safety, Side Effects, and Complication Management

Every protocol needs a safety net.
VTE risk: Favor transdermal estradiol; address obesity, immobility, smoking; consider thrombophilia screening when history suggests (Transdermal vs oral estrogen and vascular risk, 2016).
Breast health: Use the lowest effective estrogen dose with micronized progesterone; personalize imaging cadence and assess family history; emphasize exercise and alcohol moderation (Chlebowski et al., WHI breast cancer follow-up, 2020).
Prostate: In men, baseline PSA and DRE per guidelines; avoid initiating in untreated high-risk contexts; recheck PSA after stabilization (Endocrine Society Guideline, 2018).
Erythrocytosis: Adjust testosterone, check sleep apnea, ensure hydration; use phlebotomy only when clinically necessary (Sleep apnea and erythrocytosis, 2012).
Mood changes: Avoid sharp injection peaks; consider the topical route or adjust the frequency; evaluate sleep and micronutrient status.
Abnormal uterine bleeding: Verify endometrial protection, evaluate dosing, consider ultrasound; rule out structural causes.
Acne/hirsutism: Dose-adjust and assess DHT; consider 5α-reductase modulation case-by-case and discuss fertility.
Clinical observation: The highest-risk side effects occur when therapy starts without adequate risk stratification or when dose escalation outruns monitoring. Most complications abate with dose correction, route change, and terrain optimization.

Integrating Lifestyle, Behavior, and Shared Decision-Making

Hormones amplify what lifestyle initiates. Without sleep consolidation, resistance training, cardiorespiratory fitness, and nutritional adequacy, hormone therapy underperforms.
Exercise:
Resistance training enhances bone mineral density and insulin sensitivity.
Aerobic work improves endothelial function.
Both attenuate aromatase via fat loss (Exercise and bone metabolism, 2020).
Nutrition:
Adequate protein, fiber, and phytonutrient diversity support the microbiome and detox pathways.
Alcohol moderation reduces estrogenic load and breast risk.
Stress regulation:
Elevated cortisol undermines sex steroid signaling; mind–body practices and sleep hygiene are essential.
I emphasize shared decision-making, present risks and benefits with data, and align plans with patient values. Education transforms adherence and safety.

Practical Algorithm: Putting It All Together

Evaluate baseline: history, goals, cancer/prostate/VTE risk, sleep, mood, cardiometabolic markers, body composition, GI function.
Correct terrain: sleep, nutrition, movement, microbiome support, micronutrient deficits.
Select modality: choose delivery route aligned with risk; start low and titrate based on symptoms and labs.
Support metabolism: use diet and targeted supplements; monitor estrogen metabolites when indicated.
Monitor and adjust: schedule labs and visits; use symptom scores; adjust dose/frequency/route to sustain physiologic targets.
Prevent and manage side effects: anticipate, educate, and intervene early; document shared decisions and outcomes.

EEstrogen’sCritical Window, WHI Misconceptions, and Modern Guidelines

The Women’s Health Initiative (WHI) used conjugated equine estrogens (CEE) and medroxyprogesterone acetate (MPA), not bioidentical molecules. Early risk signals were concentrated in the progestin arm, yet headlines generalized these findings to all hormones (Manson et al., WHI outcomes, 2013). Subsequent analyses demonstrated nuance:
Estrogen-alone in hysterectomized women showed neutral to beneficial patterns for some endpoints, including breast cancer incidence and mortality (Chlebowski et al., 2020).
The critical window hypothesis supports starting therapy near menopause to optimize vascular and neuroprotective effects (Maki & Henderson, Critical window, 2016).
Modern guidance emphasizes individualization, rejects routine discontinuation at age 65, and supports continuation when risk–benefit is favorable (NAMS 2017 Position Statement, 2017; NAMS 2022 Update, 2022; ACOG Practice Bulletin, 2023).
My practice aligns with these updates by prioritizing bioidentical 17β-estradiol and micronized progesterone, favoring transdermal routes, and personalizing plans.

Estradiol, Cardiovascular and Brain Protection, and Discontinuation Risks

A body of evidence indicates that appropriately destradioladiol improves vascular and metabolic health, reduces events, and supports neuroprotection:
Endothelial benefits via NO synthase activation, reduced NF-κB, improved lipids, and plaque stability (Mendelsohn & Karas, Cardiovascular effects of estrogen, 2005).
Neuroprotection through PI3K/Akt, ERK, BBB integrity preservation, and microglial modulation (Liu et al., Estradiol neuroprotection, 2007; Arevalo et al., 2015).
Abrupt estrogen withdrawal increases cardiac and stroke risks due to autonomic destabilization, vascular tone shifts, and coagulation changes; tapering is safer (Grodstein et al., HT discontinuation CV implications, 2003).
In practice, I counsel patients on continuity and, when needed, careful tapering, while maintaining protective lifestyle interventions.

Testosterone–Estradiol Synergy and Avoiding Aromatase Inhibitors in Men

Estradiol and testosterone synergize to improve lipids, insulin, and visceral fat. Routine AI use can blunt these benefits:
Bisphenol A raises pain sensitivity, worsens metabolic parameters, and undermines bone health (Henry et al., AI musculoskeletal symptoms, 2018; Handelsman, Estrogen in men’s bone health, 2013).
Allowing physiological aromatization supports the integrity of the brain, bone, vascular, and metabolic systems.
I avoid routine AIs, monestradioladiol rather than preemptively blocking it, and use body composition strategies to modulate aromatization.

Sexual Health, Genitourinary Support, and MMen’sEstrogen Balance

Estrogen influences libido, arousal, vaginal mucosa, pelvic floor, and urogenital health. In men, balaestradiol supports libido, endothelium, and bone. I pair estradiol with local therapies (e.g., vagestradiol or DHEA) and pelvic rehab when indicated, while ensuring mmen’sE2/T ratios remain physiological.

My Clinical Observations: Translating Research into Outcomes

From my practice at Chiromed and collaborative care settings:
Women initiating transdermal 17β-estradiol near menopause report rapid improvements in cognition, sleep, and vasomotor symptoms; over 6–12 months, we see improvements in lipids, lower CRP, and better glycemic metrics with nutrition and resistance training.
Adding micronized progesterone stabilizes mood and sleep; patients report deeper, more restorative rest.
Thoughtful androgen support in women can enhance energy, bone, and sexual desire; monitoring hair/skin/lipids guides dosing.
Chronic pain patients often exhibit hormonal insufficiency; corticosteroids and progesterone reduce central sensitization; when combined with myofascial care, strength training, and anti-inflammatory nutrition, outcomes improve.
Deprescribing occurs naturally: fewer sedatives as sleep normalizes, reduced antidepressants with neurosteroid support, lower antihypertensives as endothelial function and autonomic tone improve.
Explore my clinical insights:
https://chiromed.com/
https://www.linkedin.com/in/dralexjimenez/

Practical Protocol Considerations and Rationale

I design protocols to match physiology, goals, and safety:
Comprehensive assessment:
Menstrual history, vasomotor symptoms, cognition, mood, sexual health, fracture risk, cardiometabolic markers, and family history.
Estradiol:
Initiate transdermal 17β-estradiol for brain, vascular, and bone signaling due to receptor congruence and lower thrombotic risk.
Progesterone:
Add oral micronized progesterone for uterine protection and neurocalm; avoid progestins due to their receptor promiscuity and immune effects.
Androgens:
Consider low-dose testosterone in women for bone, muscle, and libido with careful monitoring; in men, maintain physiologic dosing and avoid routine AIs.
Lifestyle medicine:
Progressive resistance training, zone-2 cardio, sleep optimization, stress management, and a phytonutrient-rich diet.
Gut–hormone axis:
Address dysbiosis, increase fiber and polyphenol intake, support liver detoxification, and normalize enterohepatic cycling.
Monitoring:
Track symptoms, vitals, lipids, CRP, glucose/insulin, DEXA, endometrial status, and cognitive screening as needed.
Each element is chosen to advance patient goals and respect biological signaling.

Myths and Misconceptions Corrected


strogen causes breast cancer.””Evidence differentiates molecules: risks increased with progestin combinations started late in WHI; estrogen-alone data show neutral/beneficial patterns in specific groups. Bioidentestradiol with progesterone is distinct from CEE+MPA (Chlebowski et al., 2020; NAMS 2022 Update, 2022).
“”ll hormones are the same.””False. 17β-estradiol and micronized progesterone are physiologically coherent; synthetic analogs have different receptor promiscuity and effects (Stanczyk et al., 2013).
“top at 65.” Not evidence-based; discontinuation reverses gains. Continuation should be individualized (NAMS 2017 Position Statement, 2017; NAMS 2022 Update, 2022).
“Only treat hot flashes.””Estrogen is a longevity hormone that affects the brain, bones, heart, immune system, and sexual health.

Conclusion: Modern, Evidence-Based Hormone Optimization

Estrogen, specifically 17β-estradiol, paired with micronized progesterone, and testosterone where appropriate, supports neuroprotection, bone strength, cardiovascular resilience, immune modulation, and sexual vitality. Outcomes depend on molecule, route, dose, timing, and systemic context. By embracing modern evidence and systems biology, we can reduce polypharmacy, elevate quality of life, and practice true preventive medicine.

References

About Dr. Alexander Jimenez

Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, provides integrative, functional, and evidence-based musculoskeletal and metabolic care. Clinical insights and educational resources are available at:
https://chiromed.com/
https://www.linkedin.com/in/dralexjimenez/

Keywords


hormone optimization, estrogen therapy, testosterone therapy, progesterone benefits, bioidentical hormones, transdeestradioladiol, micronized progesterone, androgen receptor, estrogen receptor, estrogen metabolites, COMT, methylation, estrobolome, microbiome, β-glucuronidase, bile acids, insulin sensitivity, bone density, cardiovascular risk, neurosteroids, sleep, erythrocytosis, prostate monitoring, VTE risk, functional medicine, clinical protocols, dosing strategies, side effect management, longevity, preventive medicine

Disclaimer


This educational content is for informational purposes only and does not constitute medical advice. Do not start, stop, or change any medication or therapy without consulting your qualified healthcare provider.

SEO tags: hormone optimization, bioidentestradiol, micronized progesterone, transdermal estrogen safety, testosterone therapy men, aromatase inhibitors risks, menopause brain health, dementia prevention estrogen, cardiovascular endothelial function estrogen, bone density menopause therapy, estrobolome gut hormones, functional medicine hormone therapy, VTE risk transdermal estrogen, progesterone neurosteroid sleep, erythrocytosis testosterone management, Dr. Alexander Jimenez DC APRN FNP-BC, evidence-based endocrinology, WHI misconceptions and modern guidelines, NAMS hormone therapy position, androgen therapy women, deprescribing with hormone optimization

Proactive Healthcare: Putting Patients at the Center

Proactive Healthcare: Putting Patients at the Center

Proactive Healthcare: Putting Patients at the Center

Abstract

This educational post explores the critical need for a paradigm shift in modern medicine, moving from a reactive, symptom-based model to a proactive, patient-centered approach. I will explore the historical context of our current healthcare system, examining the influence of industry and standardized protocols that have led to a “pill for every ill” mentality. We will critically analyze the widespread use of medications like statins and their potential long-term consequences, particularly concerning cognitive health, supported by recent evidence. This discussion will highlight the physiological importance of cholesterol and the risks associated with its suppression. Furthermore, we will address the need for personalized, integrative medicine that accounts for an individual’s unique genetic makeup and lifestyle. I will present a case for prioritizing nutrition, hormone optimization, and root-cause analysis in clinical practice. The goal is to empower fellow practitioners to transcend the limitations of conventional sick care and embrace a proactive wellness model that restores vitality to our patients and reinvigorates our professional calling.


The Historical Shift Towards a Protocol-Driven Model

To understand where we are headed in healthcare, we must first look back at our journey. In the 1800s, medicine began to organize around structured protocols. By the early 1900s, the convergence of science and industry had fundamentally reshaped the landscape. Figures like John D. Rockefeller recognized the immense financial potential within the medical field. Now, let me be clear: I firmly believe that practitioners who do excellent work should be well-compensated. You are saving and improving lives, and your partnership in healing deserves reward.

However, we must also acknowledge the historical precedents where profit has taken precedence over well-being. Industries built around sugar, processed foods, and tobacco generated billions in revenue while contributing to widespread illness and death. When we see this pattern, we must question the systems that allow it.

A major shift occurred in the 1980s with the rise of Big Pharma. This era marked a fundamental shift in medical thinking, moving away from individualized care and toward standardized, protocol-driven treatments. A pivotal moment was in 1987, with the introduction of the first statin medication. This event solidified a new clinical mindset: run a blood test, identify a number that falls outside a “normal” range, and prescribe a pill to correct it. This reductionist approach has shaped the healthcare environment we navigate today.

The Statin Epidemic: Questioning the War on Cholesterol

Let’s examine the most prescribed medications in the United States to understand the scale of this issue. While drugs like metformin and ibuprofen are widely used, statins lead the pack. It’s estimated that by 2025, over 200 million patients will be on a statin. For decades, the prevailing dogma has been to suppress cholesterol levels at all costs. As a clinician, I’ve seen the real-world impact of this practice, and the evidence now compels us to question it.

What do we know about cholesterol? It is not an enemy to be eradicated. Physiologically, it is a foundational component of cellular health. Your brain, by volume, is predominantly built from cholesterol. It is essential for the formation of cell membranes, the synthesis of hormones (like estrogen, testosterone, and cortisol), and the production of vitamin D. When we aggressively lower cholesterol, especially in our aging and hospitalized patients, we are systemically depleting a critical building block.

  • Brain Health and Cholesterol: We are now facing an epidemic of Alzheimer’s disease and other forms of dementia, conditions once considered rare. A growing body of research suggests a correlation between low cholesterol levels and an increased risk of cognitive decline (Sparks et al., 2006). By shrinking the brain’s essential raw material, are we inadvertently contributing to this crisis?
  • Immune Function and Cholesterol: A fascinating study published in February 2025 revealed that cholesterol plays a vital role in fueling dendritic cells, which are key communicators in our immune system. These cells are activated by tumors and help orchestrate a robust immune response against cancer, particularly lung cancer (Ringel et al., 2023). Yet, the standard practice remains to “crush” cholesterol with statins. We must ask if this approach is undermining our body’s innate ability to defend itself.

The “here’s your number, here’s your pill” model is failing us. It treats a lab value as a number on a piece of paper, not the complex human being behind it.

The Systemic Challenge: Big Pharma, Insurance, and Government

The complexities of our healthcare system were amplified in 2010 with the endorsement of the Affordable Care Act. This brought Big Pharma, big insurance, and big government into the same room, all with a vested interest in the industry’s financial mechanics. The global pharmaceutical industry’s net profit in 2024 was an estimated 1.7 trillion dollars. This is pure profit, not top-line revenue. This immense financial success has been achieved within a system that spends trillions annually on “healthcare” while our population grows sicker.

This is the clinical reality I see in my practice and one you likely witness every day. Patients are not getting well. They are being managed, their symptoms bandaged, but the underlying drivers of disease remain unaddressed. This approach is not healing; it’s a cycle of symptom suppression that often leads to more prescriptions to manage the side effects of the first.

The Call for Personalized, Proactive Healthcare

A growing number of patients and practitioners are questioning this broken model. They are demanding something different, something more. The truth is, choice isn’t optional; it’s everything. Medicine has somehow forgotten this fundamental principle. A one-size-fits-all approach is illogical. We are all genetically and biochemically unique. How can we possibly expect the same dose of the same medication, following the same rigid protocol, to work for everyone? It defies common sense.

Today, we stand at a crossroads. We have a choice:

  • Continue as reactive sick-care professionals, waiting for disease to manifest before intervening.
  • Become proactive healthcare providers, empowering our patients to build and maintain wellness.

This requires a shift in mindset. We should aim for our patients to see us to stay well, not just because they are sick. It also requires humility. As a profession, what if admitting we were wrong about certain long-held beliefs is the most important thing we can do to get it right? It takes character to step back from dogma, look at the new evidence, and say, “There is a better way.”

Restoring Curiosity, Humanity, and Critical Thinking

To move forward, we must reintroduce three essential elements into our practice:

  1. Curiosity and Science: We must be lifelong learners, constantly evaluating new research. The principles of functional and integrative medicine are not based on conjecture but are backed by multiple studies. We must be willing to dig deeper and ask why a patient is experiencing symptoms. A person is not Prozac deficient; they are depressed for an underlying reason. Our job is to uncover that root cause.
  2. Humanity: We must remember that we are treating patients, not paper. How often do we find ourselves focused on lab results, reciting numbers, instead of looking our patient in the eye and engaging in a real conversation? The patient’s story, their lived experience, is as crucial as any lab value. We treat fathers, mothers, teachers, and grandparents—the very fabric of our society. Their well-being has a ripple effect on us all.
  3. Critical Thinking: We must challenge the status quo and not accept information without scrutiny. The COVID-19 pandemic, for many of us, was a stark reminder of how easily critical thinking can be suspended in favor of a singular, top-down narrative. When a Stanford virologist stated early on that a safe and effective vaccine would take a minimum of three to four years to develop based on all established scientific standards, it highlighted the unprecedented speed and subsequent controversy of what transpired. I encourage you to question everything, even the information presented here. Take the studies we provide, research them, and come to your own informed conclusions.

The Promise of Integrative and Nutritional Medicine

The good news is that the tide is turning. Major institutions are beginning to acknowledge the vital role of nutrition. A recent article from Johns Hopkins Medicine championed the idea that future doctors will advise on nutrition, fostering a more holistic and comprehensive approach to health (Johns Hopkins Medicine, 2024). This is something we in the functional medicine community have advocated for decades. As I’ve often said, your cells don’t know if they are Republican or Democrat; they only know if they are nourished or starved. Addressing nutrition is not an “alternative” therapy; it is a foundational pillar of health that significantly improves patient outcomes.

Similarly, the evidence supporting the protective roles of hormones is finally gaining traction. For years, we’ve taught that estrogen, when properly balanced and administered, does not cause cancer but, in fact, helps protect the heart, brain, and bones by preventing osteoporosis. The FDA’s willingness to reconsider its stance is a monumental step forward (U.S. Food & Drug Administration, 2023).

Overcoming Cognitive Inertia

One of the biggest obstacles to progress is cognitive inertia—the tendency to stick with default mental models and resist new information that challenges our existing beliefs. It’s confirmation bias in action. Statistically, about 20% of practitioners who attend advanced training and learn new, evidence-based protocols will never implement them. They will return to their comfort zone.

Albert Einstein famously said, “We cannot solve our problems with the same thinking we used when we created them.” We must consciously break free from this inertia. We must move from treating the masses to treating the individual. We must embrace personalized medicine while never losing sight of our shared humanity.

Your Role in the Future of Medicine

Today, March 27, 2026, marks a new beginning. Just as 1987 ushered in the era of the statin, today can be the day you commit to transforming your practice. History doesn’t remember the practitioners who simply followed the system; it remembers those who transformed it. That responsibility now belongs to you.

You have the choice to stay in your comfort zone or to make a change. This is about more than just a new treatment modality; it is about regaining the calling that brought you to medicine in the first place. It’s about seeing your patients return to you not with the same complaints, but with stories of transformation: “You saved my life. You saved my marriage.”

Let’s commit to a new path:

  • Let’s treat patients, not cases.
  • Let’s provide proactive healthcare, not reactive sick care.
  • Let’s be integrative, not just allopathic.
  • Let’s become wellness care providers.

This is our finest hour. Medicine is at a pivotal point, and we are the ones who will drive the change. By restoring freedom to our practice and our patients—freedom from outdated dogma, from censorship, and from a system that ignores our humanity—we can help our communities truly thrive.


References

Root-Cause Healing Techniques for Pain Symptom Management

Explore symptom management and root-cause healing for effective health solutions. Discover natural approaches to restore balance.

Introduction and Abstract

As a Doctor of Chiropractic and a Family Nurse Practitioner (FNP-APRN), I have pursued a career that has been a journey through diverse yet complementary realms of healthcare. This unique dual perspective has afforded me a panoramic view of our healthcare system—its remarkable strengths and its profound, often frustrating, weaknesses. It’s a system where I’ve witnessed both miracles of modern medicine and the quiet desperation of patients left behind by a one-size-fits-all, symptom-masking approach. Here at our clinic in El Paso, we see the real-world consequences of this dichotomy daily. Patients arrive disheartened, having been passed from specialist to specialist, their symptoms managed with an ever-growing list of prescriptions, but their underlying health issues left unaddressed. They are tired of being told their labs are”normal” when they feel anything but. This experience is not unique to our practice; it’s a narrative echoing across the country, a clear signal that the conventional model is failing a significant portion of our population.

This post is a call to action, a synthesis of insights from forward-thinking leaders and my own clinical observations, presented not as a rigid lecture but as a shared exploration into the future of medicine. We stand at a critical juncture. For too long, the practice of medicine has been drifting away from its core tenet: to heal. It has become entangled in a web of insurance company protocols, pharmaceutical influence, and a reactive “sick-care” model that waits for disease to manifest before taking action. The focus has shifted from the patient to the paperwork, from critical thinking to algorithmic treatment, and from root cause resolution to symptom suppression. We will delve into the historical currents that brought us to this point, tracing the evolution of medical practice from the observational methods of the 1700s to the seismic shift in the 1980s, marked by the rise of “Big Pharma” and the advent of symptom-based treatment, epitomized by the widespread prescription of statins.

We will critically examine the consequences of this trajectory: a sicker, more medicated population despite unprecedented healthcare spending. We will explore the physiological fallacies of certain long-held beliefs, such as the aggressive suppression of cholesterol, and connect this practice to the alarming rise in neurodegenerative diseases like Alzheimer’s. Furthermore, we will dissect the “unholy alliance” formed in the 2010s between government, large insurance corporations, and the pharmaceutical industry, an alliance that has prioritized profits over patient outcomes and stripped both practitioners and patients of their autonomy and choice.

However, this is not a story of despair but one of empowerment and hope. The tide is turning. We will highlight the exciting paradigm shift towards a more empowered, personalized, and integrated model of healthcare. This future is rooted in root cause medicine, leveraging scientific breakthroughs to treat the individual, not just their symptoms. We will discuss the pivotal role of hormone optimization, the foundational importance of thyroid function, and the undeniable impact of nutrition—areas that are finally gaining the mainstream recognition they deserve, as evidenced by recent shifts in FDA guidance and government health initiatives. We will champion the principles of medical freedom, integrated therapies, and the profound power of the practitioner-patient partnership. This post is a manifesto for a new era of “well-care providers,” dedicated not just to managing disease but to restoring health, vitality, and life itself. It’s about reclaiming our calling as healers and empowering our patients to thrive.


A Call for Unity and Vision in Modern Healthcare

From my vantage point as a clinician on the front lines, it’s often challenging to pause and reflect on the broader trajectory of our profession. The day-to-day demands of patient care, charting, and navigating the complexities of the healthcare system can be all-consuming. That’s why I believe it’s essential for us, as a community of practitioners, to come together, to share our vision, and to realign with the core principles that drew us to this calling. We are here not just to manage symptoms but to transform healthcare fundamentally.

This mission requires a confluence of passion, business acumen, and an unwavering commitment to the patient. It’s about fighting for medical freedom—the freedom for you, the practitioner, to practice medicine based on the latest science and your clinical judgment, not dictated by restrictive insurance protocols or outdated institutional dogma. It’s about defending the patient’s right to choose treatments that are best for their unique physiology and health goals. This fight involves challenging regulatory bodies like the FDA when their guidance lags behind the evidence. Still, it also means working in partnership with them to forge a path forward that prioritizes patient well-being. The ultimate vision is simple yet profound: to always do the right thing for the people who entrust us with their health. We are moving beyond a system that waits for people to get sick and are instead embracing a proactive, evidence-based approach that we know works. It’s about building a community of courageous practitioners who dare to practice real, restorative medicine.

The Power of a Connected Community

Practitioners who choose to step outside the conventional, symptom-focused model are often pioneers charting a new course. This path can be isolating. Traditional medical training doesn’t always equip us for this journey. That is why a network —a community of like-minded colleagues —is not just a benefit—it’s a necessity. We need a support system that provides both a full medical and business framework, because success in this new paradigm requires excellence in both. It is the fusion of science, clinical application, and practice management that allows us to deliver the life-changing results our patients deserve. When we help providers successfully implement therapies that address the root cause of chronic disease, we are taking a monumental step forward in our collective mission. The focus must always be reevaluated in relation to the patient and their outcomes. The stories we hear in our clinics every day—the parent who has more energy for their children, the professional who regains their cognitive edge, the individual who feels they are truly living again—are the ultimate validation of our work.


The History of the Future: Learning from Our Past to Build a Better Tomorrow

To understand where we’re going, we must first understand how we arrived at our present moment. The phrase “the history of the future of medicine” may sound paradoxical, but it encapsulates a critical truth: our path forward is illuminated by the lessons of our past. Where we have been is not our destination. The healthcare field, for all its innovation, has a powerful inertia, a tendency to get stuck in outdated practices and ways of thinking. We, as clinicians dedicated to evidence-based medicine, must constantly challenge this status quo. We must remember that what we do is grounded in the scientific method—observation, hypothesis, testing, and conclusion. Many who enter our field have not been trained to think this way, but it is the bedrock of responsible and effective care.

We are living through a pivotal moment in medical history. To appreciate its significance, we must look back at what was once considered “modern medicine.”

A Sobering Look at “Standard of Care” Through History

It’s easy to look back with an air of superiority, but these practices were once the pinnacle of medical science, accepted and performed by the leading physicians of their day.

  • Bloodletting: For centuries, the concept of balancing the body’s “humors” dominated medical thought. If a patient was ill, it was believed they had an excess of “bad blood.” The logical, standard-of-care solution? Remove it. This seems barbaric to us now, but it was once modern medicine.
  • The Lobotomy: Consider the lobotomy. This procedure, which involved severing connections in the brain’s prefrontal cortex, was awarded a Nobel Prize in 1949. It was considered a revolutionary treatment for mental illness. It’s a chilling fact that menopausal women, likely suffering from the profound and misunderstood hormonal shifts of that life stage, were among the most frequent recipients of this brutal procedure.
  • Electroshock Therapy: While a more refined version (electroconvulsive therapy or ECT) is still used today in specific, severe cases of depression, its early application was often crude and used far more indiscriminately than is now considered ethical or effective.
  • Outdated State Regulations: Even today, we see remnants of this backward thinking. If we were to examine the official regulations for Hormone Replacement Therapy (HRT) from the medical boards of certain states, we would find guidelines that directly oppose decades of established scientific evidence and what we know is best for patient health. This isn’t ancient history; this is the reality practitioners are navigating right now.

This historical review serves as a crucial reminder: standard of care” is a moving target and not infallible. What is accepted today may be condemned tomorrow. Our duty as clinicians is not to unthinkingly follow protocol but to critically evaluate it in the light of emerging evidence and the fundamental principles of physiology.


Tracing the Path to Symptom-Based Medicine: A Historical Timeline

How did we get here? The shift from holistic, patient-centered care to a protocol-driven, symptom-masking system was not a sudden event but a gradual evolution over centuries.

  • 1700s: In this era, medicine was a craft largely based on observation, tradition, and a very limited scientific understanding. The tools were primitive; the microscope was considered high technology. Treatments were passed down through generations of physicians, with efficacy judged more by anecdotal success than rigorous study.
  • 1800s: The 19th century brought a new level of organization to the medical profession. Medical schools became more formalized, and the scientific method began to take root, with groundbreaking discoveries in microbiology and anesthesia transforming the practice.
  • Early 1900s: The confluence of science and industry began to reshape healthcare. This period saw the rise of the modern hospital and the beginning of a shift from highly personal, individualized care toward more standardized, protocol-driven treatment. This wasn’t inherently negative; protocols can save lives in acute situations. However, it laid the groundwork for a less individualized approach.
  • 1900s to 1980s: A fundamental and insidious shift in medical thinking occurred during these decades. The concept of staying within the standard of care” became paramount. While intended to protect patients from reckless experimentation, this emphasis had an unintended and detrimental side effect: it began to stifle critical thinking. Practitioners were increasingly encouraged to follow the established algorithm rather than question why it existed or whether it was truly serving the individual patient.
  • The 1980s and the Rise of Big Pharma: This decade marked the true inflection point. The pharmaceutical industry, or Big Pharma,” emerged as a dominant force in healthcare. In 1987, the first statin drug was approved and prescribed. This event marked the dawn of a new era—an era dedicated to treating symptoms with specific, patentable molecules, often without a thorough investigation into their root causes.

The Pill-for-an-Ill Epidemic

The educational model for physicians began to be heavily influenced, if not outright funded, by drug companies. The message was simple and seductive: for every symptom, there is a pill. For every side effect from that pill, there is another pill. We forgot to ask the most important question: Why is the symptom there in the first place?

If we look at the most prescribed medications from recent years, the list is dominated by drugs for conditions like high blood pressure, high blood sugar, high cholesterol, and hypertension. In 2022, hundreds of millions of prescriptions were written for these conditions. But let’s step back and ask a fundamental question: Can’t many, if not most, of these issues be profoundly addressed, or even reversed, through changes in diet and lifestyle? We forgot this crucial piece of the puzzle because we were being educated by an industry that profits from selling pills, not from promoting lifestyle changes.


The Cholesterol Conundrum: A Case Study in Flawed Thinking

Let’s use cholesterol as a specific, powerful example of how this symptom-focused thinking has permeated medicine and caused widespread harm. For decades, the mantra has been relentless: “Get your cholesterol down.” We’ve been taught to view cholesterol as an enemy to be vanquished at all costs.

The Shifting Sands of “Normal”

Have you ever noticed that the “target number” for healthy cholesterol levels seems to be a moving target? It started around 200 mg/dL being acceptable. Then, the push was to get it lower, and lower still. Now, some guidelines are creeping back up. It’s almost as if the target number is less dependent on human physiology and more dependent on which new statin drug is being marketed and what level is required to justify its prescription for a wider population.

Cholesterol’s Critical Role in Physiology

The crusade against cholesterol overlooks its essential functions in the human body. Here’s what the “drive it down” narrative misses:

  1. Brain Volume and Function: Your brain is the most lipid-rich organ in your body. Cholesterol is a fundamental building block of myelin, the fatty sheath that insulates nerve cells and allows for rapid, efficient communication between neurons. Cholesterol is literally the structural scaffold of your brain volume. Is it any surprise, then, that as we have aggressively suppressed cholesterol levels since the late 1980s, we have witnessed a concurrent and terrifying rise in neurodegenerative conditions like Alzheimer’s and dementia? Our country never had an epidemic of Alzheimer’s before the widespread use of statins. The correlation is stark and demands our attention.
  2. Hormone Production: Cholesterol is the parent molecule for all of your steroid hormones. This includes cortisol, which manages stress and inflammation; aldosterone, which regulates blood pressure; and all of your sex hormones—testosterone, estrogen, and progesterone. When you artificially suppress the raw material, you inevitably disrupt the entire downstream production line of these vital hormones, leading to a cascade of symptoms like fatigue, low libido, mood swings, and accelerated aging.
  3. Immune System Function: This is a crucial area that is often completely ignored. A fascinating body of research, including a notable study from February 2025, has revealed that cholesterol is essential for fueling dendritic cell communication. Dendritic cells are a critical part of your adaptive immune system. They act as scouts, identifying threats like viruses, bacteria, and cancer cells, and then presenting them to your T-cells to mount a targeted attack. The research showed that robust cholesterol levels facilitate this communication, leading to a stronger immune response against cancer, with a particular effect observed in lung cancer.

When you look at the charts, the data is clear: as a society, we have systematically suppressed cholesterol, and in parallel, we have seen a rise in conditions that we now know are linked to low cholesterol—from dementia to impaired immune function. This obsession with a single biomarker, driven by pharmaceutical marketing, has caused untold suffering for millions of patients.

I see this in my practice. A patient comes in on a high-dose statin, complaining of brain fog, muscle aches, and fatigue. Their cardiologist is pleased because their LDL number is low, but the patient feels terrible. Their quality of life has plummeted. This isn’t healing. This is managing a number on a lab report at the expense of the patient’s overall health. A study from approximately five years ago issued a stark warning: based on the current trajectory of our healthcare system, the financial burden of Alzheimer’s and osteoporosis alone is projected to bankrupt Medicare by the year 2050. We are actively contributing to this crisis with our misguided war on cholesterol.

A Personal Clinical Perspective

I don’t typically rely on the traditional healthcare system for my own care, but a personal health scare drove this point home for me. Heart disease runs rampant in my family. Out of 60 relatives, 58 died from heart disease before the age of 53. I am the longest-living male in my family line, a fact I attribute to the proactive, root-cause approach I now champion.

Concerned about this history, I sought a cardiac MRI, a highly specific and preventive screening tool. I’ll never forget the waiting room—it felt cold, sterile, and impersonal, a perfect metaphor for the system itself. My insurance company, of course, refused to pay for the scan. It wasn’t deemed “medically necessary.” Think about that. With my staggering family history, a desire to proactively screen for a potentially fatal condition was not considered necessary. The system would rather wait for me to have a heart attack and then pay for the astronomically expensive acute care. This is the cold, illogical reality of a system that prioritizes reactive treatment over proactive prevention.


The Unholy Alliance: How Profit Became the Priority

If the 1980s set the stage, the 2010s saw the curtain rise on a new act. The passage of the Affordable Care Act (ACA) in 2010, while well-intentioned in its goal of expanding coverage, cemented an unholy alliance among the government, Big Pharma, and big insurance companies. This trifecta has created a closed loop in which profits are maximized and practitioner and patient autonomy are systematically eroded.

Let’s look at the numbers, because numbers don’t lie.

  • Insurance Company Windfall: Since the ACA was enacted in 2010, insurance company stocks have skyrocketed by an astonishing 1,032%. For comparison, the overall S&P 500 index grew by 251% in the same period. That is more than a fourfold outperformance. This represents over 23 billion. I am a capitalist and a firm believer in the free market. I want practitioners to be wildly successful. But there is a moral contract: if you are reaping benefits at that level, the service you are providing must work. And what they are providing is not working.
  • Pharmaceutical Profits: Big Pharma has seen similarly staggering gains. From 2000 to 2018, the 35 largest pharmaceutical companies reported a cumulative net profit of $1.48 trillion. A trillion is a thousand billion. This is their bottom-line profit, not top-line revenue.

What did we, as a society, get in return for this massive transfer of wealth? We got no healing. We got a system that excels at putting band-aids on symptoms, which inevitably leads to the progression of chronic disease. Many executives within these industries will privately admit that there is no money in a cure. The business model is predicated on keeping people chronically ill and dependent on lifelong medications.

This has led us to a national healthcare expenditure of $4.9 trillion annually. Yet, in this system, we have no real choices. As practitioners, we see it every single day. We prescribe a specific medication that we know, based on its formulation and our patient’s needs, will be effective. The patient takes it to the pharmacy, only to be told, “Your insurance won’t pay for that one, but they will pay for this cheaper, generic alternative.” We know the alternative may have different binders, fillers, or a different release mechanism and won’t work as well, but our hands are tied. The choice has been taken away from the clinician and the patient and placed in the hands of an insurance clerk whose primary metric is cost savings.

Choice isn’t optional; it’s everything. The idea that a “one-size-fits-all” approach could work in medicine is illogical. We are all a tapestry of unique genetics, epigenetics, lifestyles, and environmental exposures. How could we possibly treat every individual with the same drug at the same dose and expect an optimal outcome? It defies basic biological principles. If practitioners would step back from the algorithm and consider this simple truth, it would be a profoundly powerful moment of clarity. The result of this broken system is plain to see: we are sicker than ever, more medicated than ever, and spending more money than ever, with worse outcomes to show for it.


The Turning Tide: A New Hope for Patients and Practitioners

This is where you come in. This is where we, as a community, draw a line in the sand. You may be sitting here, feeling the weight of this dysfunctional system. But you are also in an incredibly powerful position. The frustration is palpable, not just among us, but among our patients.

  • They are arriving in our offices as an increasingly unhealthy and frustrated population.
  • They are starting to question the conventional healthcare model that has failed them.
  • They are actively demanding something different.

So, you have a choice. You can remain stuck in a reactive sick care” system, or you can embrace a proactive, root-cause-oriented future. I often ask my colleagues: Are you a Medical Doctor or a Disease Manager? Are you an MD or a DM? What we are doing, and the reason this movement is growing, is that practitioners like you resonate with this message. You know in your gut that there is a better way, and you are here because you want to do something different for your patients.

A friend of mine recently shared a quote that struck me: What if admitting we were wrong is the biggest thing we ever did right?” Perhaps this is a moment for all of us in healthcare to have the humility to admit that the path we’ve been on is wrong and to have the courage to choose a new one.

The Convergence of Science, Humanity, and Critical Thinking

A powerful convergence is happening right now. We are finally marrying cutting-edge science, a renewed focus on humanity and the patient experience, and the revival of critical thinking. We are leveraging scientific breakthroughs that have, for too long, been ignored by the mainstream.

It is baffling how slowly medicine progresses and how slowly it embraces new therapies. Think about the Women’s Health Initiative (WHI) study from the early 2000s. This deeply flawed study incorrectly linked hormone replacement therapy to increased health risks, causing widespread panic. Doctors immediately started pulling women off their hormones. We are just now, more than two decades later, beginning to unravel the immense damage caused by that one study. For years, we and others in the evidence-based community have been speaking out against its flawed methodology. In the intervening years, countless women have suffered and died needlessly from conditions that we know hormones protect against, such as heart disease, osteoporosis, and dementia. They were denied life-saving therapy because of faulty science that became institutional dogma.

The good news is, the tide is finally turning. Practitioners are no longer willing to accept “this is just how it is.” More importantly, patients are actively seeking out practitioners like you. They are searching for doctors and nurse practitioners who will listen to them, think critically, and partner with them to restore their health. We may represent the minority right now, but we are the future.

Mainstream Medicine is Starting to Listen

We are seeing encouraging signs that the mainstream is slowly catching up.

  • Nutrition in Medical Education: A headline in the Journal of the American Medical Association (JAMA) from about six months ago read, “Your future doctor may be able to advise you on nutrition.” My first reaction was, “Oh my God, you don’t say!” It’s unbelievable that this is considered a breakthrough, but it signals a crack in the old foundation.
  • Government Initiatives: Regardless of your political leanings, patient health is not a partisan issue. We should applaud positive change wherever it originates. Robert F. Kennedy Jr., for example, has advocated for linking federal funding for medical schools to the inclusion of robust nutrition education in their curriculum. For too long, big industry has infiltrated our academic institutions, promoting a pill-only approach and silencing any meaningful discourse on how diet and lifestyle impact health. If the institutions won’t change on their own, perhaps this is the leverage needed to force them to serve the public better.
  • The FDA and Estrogen: In a monumental and long-overdue decision, the FDA announced the removal of the black box warning for systemic estrogen-alone therapy just a few months ago. Hallelujah! For decades, our community has been teaching, based on overwhelming evidence, about the powerful protective benefits of estrogen. We know it protects the brain, builds bone density, and, contrary to the old myths, protects breast tissue. This is a massive victory for evidence-based medicine and, most importantly, for the health of millions of women.
  • Revisiting the Food Pyramid: Another recent development saw the inversion of the traditional food pyramid, with a new emphasis on higher protein and healthy fats, more closely aligning with the dietary protocols we have been recommending for years.

When leaders from across the political spectrum—from RFK Jr. to the Director of HHS—begin to champion these common-sense, evidence-based principles, it’s a sign that our message is breaking through. We must unite as a medical community to applaud these steps forward, as they ultimately benefit our patients.


Empowered, Personalized Healthcare: The Apexius Health Solutions Approach

This brings us to the core of what we believe the future of medicine will be: empowered, personalized healthcare. This philosophy is built on several guiding principles.

1. Fighting for Medical Freedom

This is our non-negotiable foundation. As a representative of this community, I regularly travel to Washington, D.C., to meet with members of Congress and leaders at HHS and the FDA. I have testified before the FDA on multiple occasions regarding the safety and efficacy of therapies like peptides. At the heart of the regulatory push to restrict access to these powerful tools is the fundamental issue of medical freedom. We are fighting for your right, as a practitioner, to use every safe and effective tool available, and for patients’ right to choose their path to health. We do this not with political rhetoric but with the scientific method—presenting facts, data, and outcomes.

2. Integrated Medicine

True health is not achieved through a single intervention. It requires a holistic, integrated approach. We must look at the whole person. Yes, we will use hormone optimization. Yes, we will address thyroid function. Yes, we will prescribe nutritional supplements and peptides. But we will also address what you are eating, how you move, how you sleep, and how you manage stress. It is the synergy of all these elements that leads to patients living happier, healthier, more vibrant lives.

3. Root Cause Healing

This is the intellectual and clinical core of our practice. A patient presents with a splitting migraine. The conventional approach is to prescribe a drug to abort the headache. As long as they take the drug, the headache is managed. When they stop, it returns. The next step? Up the dose. This is not a solution. The correct approach is to ask WHY the patient is having migraines. Is it a food sensitivity? A hormonal imbalance? A nutrient deficiency? A structural issue in the cervical spine? We must be medical detectives, finding the cause of the problem and treating it. This approach is not championed by the mainstream system because there is little profit in finding and fixing the root cause.

4. Partnership with You

We use the word partnership” intentionally. We are not a vendor; we are your partner. We are here to support you in every aspect of your practice, from clinical education to business development. We dig deeper and treat smarter. We take a positive, integrative approach to medicine and strive to make the plan simple for both you and your patients.

Making the Plan Simple: The Foundation of Compliance

There are countless complex diets and healthcare regimens out there. But what do patients truly want? They want simplicity. They are used to the conventional model: “Take my blood, give me a pill, make it simple.” While more people are waking up to the fact that this model doesn’t work in the long term, we must still meet them where they are by providing clear, manageable, and effective protocols.

Our starting point focuses on three foundational pillars:

  1. Hormone Status
  2. Thyroid Function
  3. Nutrition

This is the trifecta that governs so much of a patient’s health and well-being. By addressing these areas first, we can create profound changes. One of the reasons pellet therapy for hormone optimization is such a powerful modality is its built-in 100% patient compliance. Once the pellets are inserted, the therapy is active for the next three to six months. There is no cream to remember to rub on, no pill to take, no patch to apply. The patient doesn’t have to worry about absorption issues or daily fluctuations.

This is why following a proven method is so critical. The Avexapel method, for example, is a complete, integrated system. It’s not a buffet where you pick and choose parts. The dosing algorithm and treatment protocols are based on decades of sound medical studies and data from millions of patient encounters. If the system, based on the patient’s labs and clinical picture, recommends optimizing hormone levels, thyroid function, and progesterone, then that is the approach. Following this evidence-based protocol is what allows us to protect you. We have defended our practitioners before medical boards on 18 separate occasions. We are 18-for-18 in winning those cases. We win because we can stand on a mountain of scientific evidence that supports our protocols. However, if a practitioner deviates from the method—”I did this and this, but not that”—we cannot defend them. You are on your own. Following the system will serve you and your patients well.


The Stark Choice: Practice as Usual or Embrace a Better Way?

Look at this graph. As we age, our hormone levels naturally decline. On that same timeline, you see a dramatic increase in chronic diseases: arthritis, heart disease, cancer, diabetes, and asthma. The correlation is undeniable. Hormonal decline is a primary driver of age-related disease.

I say this with the utmost respect for the talented, experienced, and tenured professionals in our field. If you come to an educational event, learn about the critical role of hormone and thyroid optimization, see the mountains of studies supporting these therapies, understand the power of nutritional interventions, and then go back to your practice and continue with “business as usual”—is that not a form of medical malpractice? When you know better, when you have been taught better, and you choose to withhold that superior level of care from your patients, it is, in my opinion, a profound ethical failure.

We are moving from a medicine for the masses to a medicine for the individual. We are embracing personalized, precision medicine and putting the patient back at the very center of their care. This, ladies and gentlemen, is the future of medicine.

Reclaiming Our Calling

This is a story of regaining what we have lost.

  • For our patients, it’s about helping them regain their health, vitality, cognitive function, and very lives. It’s the difference between merely surviving and truly thriving.
  • For you, the practitioner, this is your story as well. It’s a return to the reasons you chose this calling in the first place. It’s the freedom to think critically and follow the science. It’s the gift of having the time to build true partnerships with your patients.

It never ceases to amaze me how we, as practitioners, sometimes forget our power. The power of the “white coat” is real. When you sit down with a patient and speak with conviction and authority, they will listen. All you have to do is tell them what to do. They are looking to you for answers.

We see it every day in our clinics. A patient comes in and says, “I’ve been to doctor after doctor. No one could figure out what was wrong with me. They just gave me more pills. You are the first person who listened, who got to the root cause, and who fixed me. My life is completely different now. It’s affected my marriage, my job, my relationship with my kids.” Witnessing these profound, life-changing transformations is the greatest reward in medicine.

This is where we come together as a team. Our organization has invested tens of millions of dollars to develop the technology, systems, processes, and educational platforms to make this a comprehensive, one-stop solution. We can teach you the medicine, help you with the business, support your marketing, and provide educational tools for your patients. It would cost an individual hundreds of thousands, if not millions, of dollars to try to replicate this infrastructure. We partner with you to provide it. You are not an observer in this story. You are on the front lines. If we, as a collective, can grasp the power at our fingertips, we can truly change the landscape of healthcare.

Let’s commit. This weekend, and every day after, let’s:

  • Treat patients, not paper.
  • Provide proactive healthcare, not reactive sick care.
  • Become more integrated and less allopathic.
  • Become “well-care providers” instead of “sick-care providers.”

Together, we can transform the practice of medicine.


Our Final Hour: A Call for Freedom and Action

Let this be our final hour of complacency. Let’s not just manage care; let’s restore health. Let’s restore vitality. And let’s restore freedom.

Freedom for you, the practitioner, to practice medicine the way it should be practiced.

Freedom for your patients from the prison of their symptoms.

Freedom from being ignored by a system that doesn’t see them.

And the freedom to pursue and live in the truth of what real health is.

I will end with this: We cannot look to anyone else to drive this change. The federal government will not fix it. State legislators will not fix it. It will be fixed by practitioners and patients, like you, standing up and demanding something different. It is up to us.

Turn to each other and say it: We can do better. Let’s not miss this opportunity to have a significant positive impact on the future. Thank you.


Summary

This educational post, presented from my perspective as Dr. Alexander Jimenez, DC, APRN, FNP-BC, serves as a comprehensive analysis of the current state of healthcare and a call to action for a new paradigm of medicine. It begins by establishing the widespread dissatisfaction with the conventional “sick-care” system, a sentiment I observe daily in my clinical practice. The introduction outlines the journey we will take: a historical deep-dive into how medicine evolved into a symptom-focused, protocol-driven industry, heavily influenced by pharmaceutical and insurance interests. We then critically examine the physiological and clinical consequences of this model, using the misguided war on cholesterol as a prime example and linking its suppression to the rise of neurodegenerative diseases. The post deconstructs the “unholy alliance” between government, big pharma, and insurance companies that has prioritized profit over patient outcomes, stripping both clinicians and patients of their autonomy.

However, the core message is one of optimism and empowerment. We highlight the turning tide toward a more enlightened approach: empowered, personalized healthcare. The discussion champions the principles of root cause medicine, integrated therapies, and medical freedom. I elaborate on the foundational importance of hormone optimization, thyroid function, and nutrition as the pillars of this new model. Key recent developments, such as the FDA’s removal of the black box warning on estrogen and a renewed focus on nutrition in medical education, are presented as evidence that this new paradigm is gaining mainstream traction. The post emphasizes the need for a strong practitioner community and the power of following proven, evidence-based methods, which not only ensure superior patient outcomes but also provide a defensible standard of care. Ultimately, this text is a manifesto for clinicians to reclaim their role as healers, to move from being “disease managers” to “well-care providers,” and to partner with their patients to restore not just health, but vitality and life itself.

Conclusion

As we conclude this exploration on January 16, 2026, the message is unequivocal: the future of medicine is not a distant dream but a present-day reality we must actively create. The history of our profession is littered with well-intentioned but ultimately harmful “standards of care” that were later abandoned. We are currently living through another such era, where the management of symptoms has tragically eclipsed the pursuit of healing. The data is irrefutable: a system that costs trillions of dollars yet leaves us sicker and more medicated is a failed system.

The path forward requires a courageous departure from this failing model. It demands that we embrace critical thinking, prioritize root cause resolution, and treat the unique individual in front of us, not a set of numbers on a lab report. The convergence of science, a renewed focus on the patient-practitioner partnership, and the growing public demand for better health offers an unprecedented opportunity. We must have the humility to admit the old ways were wrong and the conviction to forge a new path grounded in integrated, personalized, and proactive care. This is not just about changing how we practice medicine; it’s about restoring the very soul of our profession and fulfilling the promise we made to our patients: to help them regain their health, their freedom, and their lives. The change starts with us, today.

Key Insights

  • The “Sick-Care” Model is Broken: The current healthcare system is designed for reactive disease management rather than proactive health promotion, resulting in a sicker, more medicated population despite record spending.
  • Symptom Suppression vs. Root Cause Resolution: A fundamental flaw in modern medicine is the focus on masking symptoms with pharmaceuticals (e.g., statins, hypertensives) rather than investigating and treating the underlying physiological imbalance.
  • The Danger of Flawed Dogma (e.g., cholesterol): The aggressive, widespread suppression of cholesterol, a molecule vital for brain health, hormone production, and immune function, is a prime example of how pharmaceutical-driven narratives can lead to devastating public health consequences, including a rise in dementia.
  • Medical Freedom is Paramount: True patient care requires that practitioners have the freedom to think critically and use evidence-based therapies without undue restrictions imposed by insurance companies or outdated regulatory guidance.
  • The Future is Integrated and Personalized: Optimal health is achieved through a holistic approach that integrates hormone optimization, thyroid health, nutrition, and lifestyle modifications tailored to the individual’s unique physiology.
  • Practitioner and Patient Empowerment is Key: The most powerful force for change is an educated patient base and a courageous community of practitioners who demand a better standard of care and partner together to achieve it.

Keywords

Integrative Medicine, Functional Medicine, Root Cause Medicine, Hormone Optimization, Bioidentical Hormone Replacement Therapy (BHRT), Thyroid Health, Personalized Medicine, Medical Freedom, Evidence-Based Medicine, Cholesterol, Statins, Alzheimer’s Disease, Nutrition, Proactive Healthcare, Well-Care, Patient Empowerment, Dr. Alexander Jimenez, El Paso Chiropractor, Nurse Practitioner.

References

  • Journal of the American Medical Association (JAMA), on the topic of nutrition in medical education.
  • Research on cholesterol’s role in dendritic cell communication (as of February 2025).
  • Data regarding insurance and pharmaceutical company profits post-ACA (2010-2023).
  • Data on the most prescribed medications in the United States (as of 2022).
  • Historical data and analysis of the Women’s Health Initiative (WHI) study.

Disclaimer

The information contained in this post is for educational and informational purposes only and is not intended as health or medical advice. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this webpage.

All individuals must obtain recommendations for their personal health situations from their own medical providers. The author and publisher of this post are not responsible for any adverse effects or consequences resulting from the use of any suggestions or procedures described hereafter. The views and opinions expressed in this post are those of the author and do not necessarily reflect the official policy or position of any other agency, organization, employer, or company.